Unnamed: 0,activity_comment,activity_id,assay_chembl_id,assay_description,assay_type,bao_endpoint,bao_format,bao_label,canonical_smiles,document_chembl_id,document_journal,document_year,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_type,standard_units,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,toid,type,units,uo_units,value
11000,,1611613,CHEMBL871614,In vitro minimum inhibitory concentration against Staphylococcus aureus upon incubation at 37 degree C for 16 to 24 hr by dissolving in DMSO (1%),F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140385,J Med Chem,2005.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,403412,=,1,1,=,MIC,ug.mL-1,0.625,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.625
11001,,1611614,CHEMBL871616,In vitro minimum inhibitory concentration against Staphylococcus aureus (Smith) upon incubation at 37 degree C for 16 to 24 hr by dissolving in DMSO (1%),F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140385,J Med Chem,2005.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,403412,=,1,1,=,MIC,ug.mL-1,0.156,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.156
11002,,1611615,CHEMBL871622,In vitro minimum inhibitory concentration against Methicillin-resistant Staphylococcus aureus upon incubation at 37 degree C for 16 to 24 hr by dissolving in DMSO (1%),F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140385,J Med Chem,2005.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,403412,=,1,1,=,MIC,ug.mL-1,40.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,40.0
11003,,1611616,CHEMBL871613,In vitro minimum inhibitory concentration against Enterococcus faecalis upon incubation at 37 degree C for 16 to 24 hr by dissolving in DMSO (1%),F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140385,J Med Chem,2005.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,403412,=,1,1,=,MIC,ug.mL-1,2.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,2.5
11004,,1611617,CHEMBL871612,In vitro minimum inhibitory concentration against Enterococcus fecium upon incubation at 37 degree C for 16 to 24 hr by dissolving in DMSO (1%),F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140385,J Med Chem,2005.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,403412,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,10.0
11005,,1611618,CHEMBL871621,In vitro minimum inhibitory concentration against Vancomycin resistant Enterococci faecium upon incubation at 37 degree C for 16 to 24 hr by dissolving in DMSO (1%),F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140385,J Med Chem,2005.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,403412,=,1,1,=,MIC,ug.mL-1,80.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,80.0
11006,,1614697,CHEMBL884142,Minimum inhibitory concentration against Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142848,Bioorg Med Chem Lett,2005.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,404163,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
11007,,1614698,CHEMBL884143,Minimum inhibitory concentration against Staphylococcus epidermidis,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142848,Bioorg Med Chem Lett,2005.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,404163,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.5
11008,,1614699,CHEMBL884139,Minimum inhibitory concentration against Bacillus subtilis,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142848,Bioorg Med Chem Lett,2005.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,404163,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.06
11009,,1614700,CHEMBL884140,Minimum inhibitory concentration against Klebsiella pneumoniae,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142848,Bioorg Med Chem Lett,2005.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,404163,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.25
11010,,1614701,CHEMBL884141,Minimum inhibitory concentration against Pseudomonas aeruginosa,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142848,Bioorg Med Chem Lett,2005.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,404163,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
11011,,1614702,CHEMBL883206,Minimum inhibitory concentration against Escherichia coli,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142848,Bioorg Med Chem Lett,2005.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,404163,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
11012,,1667310,CHEMBL864624,Antibacterial activity against Escherichia coli ATCC 25922,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1148591,J Med Chem,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,417967,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
11013,,1667315,CHEMBL864625,Antibacterial activity against Staphylococcus aureus ATCC 29213,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1148591,J Med Chem,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,417967,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
11014,,1667320,CHEMBL869436,Inhibition of DNA gyrase supercoiling in Escherichia coli ATCC 25922,B,BAO_0000190,BAO_0000223,protein complex format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1148591,J Med Chem,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,417967,=,1,1,=,IC50,nM,600.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,IC50,uM,UO_0000065,0.6
11015,,1667325,CHEMBL854373,Inhibition of topoisomerase 4 decatenation in Staphylococcus aureus ATCC 29213,B,BAO_0000190,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1148591,J Med Chem,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,417967,=,1,1,=,IC50,nM,3500.0,CHEMBL4088,Staphylococcus aureus,Topoisomerase IV subunit A,1280.0,,IC50,uM,UO_0000065,3.5
11016,Not Active,1683699,CHEMBL861887,Binding affinity to Bacillus subtilis DNA polymerase3C,B,BAO_0000192,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1138117,J Med Chem,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,428199,,1,0,,Ki,,,CHEMBL3897,Bacillus subtilis (strain 168),DNA polymerase III,224308.0,,Ki,,,
11017,,1683726,CHEMBL862001,Antibacterial activity against Bacillus subtilis BD54,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1138117,J Med Chem,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428199,=,1,1,=,MIC,ug.mL-1,0.313,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.313
11018,,1683753,CHEMBL862003,Antibacterial activity against Staphylococcus aureus 25293,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1138117,J Med Chem,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428199,=,1,1,=,MIC,ug.mL-1,0.625,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.625
11019,,1683781,CHEMBL862058,Antibacterial activity against Staphylococcus aureus smith,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1138117,J Med Chem,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428199,=,1,1,=,MIC,ug.mL-1,0.156,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.156
11020,,1683807,CHEMBL862059,Antibacterial activity against methicillin resistant Staphylococcus aureus MRSA 1094,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1138117,J Med Chem,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428199,=,1,1,=,MIC,ug.mL-1,40.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,40.0
11021,,1683834,CHEMBL862060,Antibacterial activity against Enterococcus faecalis 29212,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1138117,J Med Chem,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428199,=,1,1,=,MIC,ug.mL-1,2.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,2.5
11022,,1683854,CHEMBL862061,Antibacterial activity against Enterococcus faecium 19434,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1138117,J Med Chem,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428199,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,10.0
11023,,1683888,CHEMBL862062,Antibacterial activity against Vancomycin resistant Enterococcus faecium VRE 700802,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1138117,J Med Chem,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428199,=,1,1,=,MIC,ug.mL-1,80.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,80.0
11024,,1683915,CHEMBL862063,Antibacterial activity against Escherichia coli J53,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1138117,J Med Chem,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,428199,=,1,1,=,MIC,ug.mL-1,1.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.25
11025,,1735346,CHEMBL864791,Antibacterial activity against Pseudomonas aeruginosa,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137433,Bioorg Med Chem Lett,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,500059,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.78
11026,,1735347,CHEMBL862937,Antibacterial activity against Escherichia coli,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137433,Bioorg Med Chem Lett,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,500059,=,1,1,=,MIC,ug.mL-1,0.36,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.36
11027,,1735348,CHEMBL862936,Antibacterial activity against Klebsiella pneumoniae,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137433,Bioorg Med Chem Lett,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,500059,=,1,1,=,MIC,ug.mL-1,0.36,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.36
11028,,1735349,CHEMBL862935,Antibacterial activity against Streptococcus faecalis,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137433,Bioorg Med Chem Lett,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,500059,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.78
11029,,1735350,CHEMBL862934,Antibacterial activity against Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137433,Bioorg Med Chem Lett,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,500059,=,1,1,=,MIC,ug.mL-1,0.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.3
11030,,1738058,CHEMBL870495,Antibacterial activity against methicillin-resistant Staphylococcus aureus 2 by agar-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1138103,Bioorg Med Chem Lett,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,512271,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.78
11031,,1738061,CHEMBL868689,Antibacterial activity against methicillin-resistant Staphylococcus aureus 1 by agar-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1138103,Bioorg Med Chem Lett,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,512271,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.78
11032,,1738068,CHEMBL868687,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 by agar-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1138103,Bioorg Med Chem Lett,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,512271,=,1,1,=,MIC,ug.mL-1,3.13,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,3.13
11033,,1738069,CHEMBL868686,Antibacterial activity against Klebsiella pneumoniae ATCC 10031 by agar-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1138103,Bioorg Med Chem Lett,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,512271,=,1,1,=,MIC,ug.mL-1,0.049,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.049
11034,,1738070,CHEMBL868685,Antibacterial activity against Escherichia coli ATCC 8739 by agar-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1138103,Bioorg Med Chem Lett,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,512271,=,1,1,=,MIC,ug.mL-1,0.049,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.049
11035,,1738072,CHEMBL868681,Antibacterial activity against Bacillus subtilis ATCC 6633 by agar-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1138103,Bioorg Med Chem Lett,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,512271,=,1,1,=,MIC,ug.mL-1,0.049,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.049
11036,,1738074,CHEMBL868684,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 by agar-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1138103,Bioorg Med Chem Lett,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,512271,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.78
11037,,1738075,CHEMBL868678,Antibacterial activity against Staphylococcus aureus ATCC 6538p by agar-dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1138103,Bioorg Med Chem Lett,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,512271,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.78
11038,,1826981,CHEMBL909713,Bacteriostatic activity against Escherichia coli DM4100 in aerobic condition,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625566,=,1,1,=,MIC,ug.mL-1,0.075,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.075
11039,,1826984,CHEMBL910810,Bacteriostatic activity against Escherichia coli DM4100 in anaerobic condition,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625566,=,1,1,=,MIC,ug.mL-1,0.075,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.075
11040,Not Active,1826989,CHEMBL910814,Bactericidal activity against Escherichia coli DM4100 in the presence of chloramphenicol,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,625566,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
11041,Active,1826992,CHEMBL910815,Bactericidal activity in Escherichia coli KD1373 containing parC mutation in anerobic condition,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,625566,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
11042,Active,1826993,CHEMBL910816,Bactericidal activity in Escherichia coli KD2750 containing gyrA resistant mutation in anerobic condition,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,625566,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
11043,Not Active,1826994,CHEMBL910817,Bactericidal activity in Escherichia coli KD2329 containing gyrA-parC mutation,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,625566,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
11044,Active,1829145,CHEMBL910813,Bactericidal activity against Escherichia coli DM4100 in anaerobic condition,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,625566,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
11045,Active,1832969,CHEMBL910811,Bactericidal activity against Escherichia coli DM4100 in aerobic condition,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,625566,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
11046,,1834052,CHEMBL855355,Antibacterial activity against Streptococcus suis ATCC 43765 after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,MIC,ug ml-1,UO_0000274,4.0
11047,,1834056,CHEMBL855356,Antibacterial activity against Streptococcus suis BB1001 isolate after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,MIC,ug ml-1,UO_0000274,2.0
11048,,1834060,CHEMBL855357,Antibacterial activity against Streptococcus suis BB1002 isolate after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,MIC,ug ml-1,UO_0000274,2.0
11049,,1834064,CHEMBL855358,Antibacterial activity against Streptococcus suis BB1003 isolate after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,MIC,ug ml-1,UO_0000274,4.0
11050,,1834068,CHEMBL855359,Antibacterial activity against Streptococcus suis BB1004 isolate after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,MIC,ug ml-1,UO_0000274,2.0
11051,,1834072,CHEMBL855360,Antibacterial activity against Streptococcus suis BB1005 isolate after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,MIC,ug ml-1,UO_0000274,4.0
11052,,1834076,CHEMBL855361,Antibacterial activity against Streptococcus suis BB1006 isolate after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,MIC,ug ml-1,UO_0000274,32.0
11053,,1834080,CHEMBL855362,Antibacterial activity against Streptococcus suis BB1007 isolate after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,MIC,ug ml-1,UO_0000274,16.0
11054,,1834084,CHEMBL855363,Antibacterial activity against Streptococcus suis BB1008 isolate after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,MIC,ug ml-1,UO_0000274,64.0
11055,,1834088,CHEMBL855364,Antibacterial activity against Streptococcus suis BB1009 isolate after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,MIC,ug ml-1,UO_0000274,32.0
11056,,1834092,CHEMBL855365,Antibacterial activity against Streptococcus suis BB1010 isolate after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,MIC,ug ml-1,UO_0000274,64.0
11057,,1834096,CHEMBL855366,Antibacterial activity against Streptococcus suis BB1011 isolate after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,MIC,ug ml-1,UO_0000274,32.0
11058,,1834100,CHEMBL855367,Antibacterial activity against Streptococcus suis BB1012 isolate after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,MIC,ug ml-1,UO_0000274,64.0
11059,,1834104,CHEMBL855368,Antibacterial activity against Streptococcus suis BB1013 isolate after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,MIC,ug ml-1,UO_0000274,64.0
11060,,1834108,CHEMBL855369,Antibacterial activity against Streptococcus suis BB1014 isolate after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,MIC,ug ml-1,UO_0000274,64.0
11061,,1834112,CHEMBL855370,Antibacterial activity against Streptococcus suis BB1015 isolate after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,MIC,ug ml-1,UO_0000274,64.0
11062,,1834116,CHEMBL855371,Antibacterial activity against Streptococcus suis BB1016 isolate after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,MIC,ug ml-1,UO_0000274,64.0
11063,,1834120,CHEMBL854309,Antibacterial activity against Streptococcus suis BB1017 isolate after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142180,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625838,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL3301404,Streptococcus suis,Streptococcus suis,1307.0,,MIC,ug ml-1,UO_0000274,64.0
11064,Active,1834538,CHEMBL910812,Bactericidal activity against Escherichia coli DM4100 in saline,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142131,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,625566,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
11065,,1847300,CHEMBL918716,Antibacterial activity against Staphylococcus aureus SA1199B overexpressing NorA at 5 ug by disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1142063,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,631991,=,1,1,=,IZ,mm,27.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,27.0
11066,,1867046,CHEMBL904486,Antimicrobial activity against Escherichia coli AG100 mutant with argE3 thi-3 rpsL xyl mtl supE44 genotype,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,MIC,ug.mL-1,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.02
11067,,1867051,CHEMBL904487,Antimicrobial activity against Escherichia coli M013 mutant with AG100 delta-(lon-hupB-ppiD) dupIS5 genotype,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,MIC,ug.mL-1,0.13,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.13
11068,,1867063,CHEMBL904488,Antimicrobial activity against Escherichia coli M043 mutant with AG100 lon4::IS186 marR::IS2 genotype,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,MIC,ug.mL-1,0.38,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.38
11069,,1867068,CHEMBL904489,Antimicrobial activity against Escherichia coli M044 mutant with AG100 lon4::IS186 marR::IS genotype,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
11070,,1867080,CHEMBL904490,Antimicrobial activity against Escherichia coli M064 mutant with AG100 lon1::IS186 acrR::IS genotype,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.19
11071,,1867085,CHEMBL904491,Antimicrobial activity against Escherichia coli M073 mutant with AG100 lon2::IS186 acrR::IS5 genotype,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.19
11072,,1867090,CHEMBL904492,Antimicrobial activity against Escherichia coli M074 mutant with AG100 lon2::IS186 acrR::IS genotype,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.19
11073,,1867102,CHEMBL904493,Antimicrobial activity against Escherichia coli M083 mutant with AG100 lon4::IS186 acrR::IS1 genotype,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
11074,,1867107,CHEMBL904494,Antimicrobial activity against Escherichia coli M084 mutant AG100 lon4::IS186 genotype,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,MIC,ug.mL-1,0.13,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.13
11075,,1867119,CHEMBL904495,Antimicrobial activity against Escherichia coli M093 mutant with AG100 lon3::IS186 acrR::IS1 genotype,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
11076,,1867124,CHEMBL904496,Antimicrobial activity against Escherichia coli M103 mutant with AG100 lon3::IS186 acrR-acrAB genotype,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
11077,,1867129,CHEMBL904497,Antimicrobial activity against Escherichia coli M104 mutant with AG100 dupIS3 genotype,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
11078,,1867141,CHEMBL904498,Antimicrobial activity against Escherichia coli M114 mutant with AG100 lon4::IS186 marR::IS2 genotype,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,MIC,ug.mL-1,0.38,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.38
11079,,1867146,CHEMBL904499,Antimicrobial activity against Escherichia coli M124 mutant with AG100 lon4::IS186 acrR::IS genotype,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
11080,,1867170,CHEMBL904500,Antimicrobial activity against Escherichia coli AG112 mutant with AG100 marR genotype,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,MIC,ug.mL-1,0.38,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.38
11081,,1867174,CHEMBL904501,Antimicrobial activity against Escherichia coli AG112 mutant with marR genotype after 250 generations in 5 ug/ml presence of tetracycline,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
11082,,1867178,CHEMBL904502,Antimicrobial activity against Escherichia coli AG112 mutant with marR genotype after 125 generations in absence of tetracycline,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1146193,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634725,=,1,1,=,MIC,ug.mL-1,0.75,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.75
11083,Active,1868733,CHEMBL920177,Antimicrobial activity against Pseudomonas aeruginosa P21.21 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11084,Active,1868744,CHEMBL920178,Antimicrobial activity against Pseudomonas aeruginosa 65.18-1 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11085,Active,1868753,CHEMBL920179,Antimicrobial activity against Pseudomonas aeruginosa 65.18-2 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11086,Active,1868762,CHEMBL920180,Antimicrobial activity against Pseudomonas aeruginosa 65.18-3 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11087,Active,1868772,CHEMBL920181,Antimicrobial activity against Pseudomonas aeruginosa 65.18-4 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11088,Active,1868782,CHEMBL920182,Antimicrobial activity against Pseudomonas aeruginosa P21.23 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11089,Active,1868793,CHEMBL920183,Antimicrobial activity against Pseudomonas aeruginosa IA5 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11090,Active,1868804,CHEMBL920184,Antimicrobial activity against Pseudomonas aeruginosa IC7 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11091,Active,1868815,CHEMBL920186,Antimicrobial activity against Pseudomonas aeruginosa 65.33-1 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11092,Active,1868825,CHEMBL920187,Antimicrobial activity against Pseudomonas aeruginosa 65.33-2 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11093,Active,1868834,CHEMBL920188,Antimicrobial activity against Pseudomonas aeruginosa 65.33-3 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11094,Active,1868842,CHEMBL920189,Antimicrobial activity against Pseudomonas aeruginosa 65.33-4 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11095,Active,1868851,CHEMBL920190,Antimicrobial activity against Pseudomonas aeruginosa 65.36-1 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11096,Active,1868860,CHEMBL920191,Antimicrobial activity against Pseudomonas aeruginosa 65.36-2 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11097,Active,1868870,CHEMBL920192,Antimicrobial activity against Pseudomonas aeruginosa 65.36-3 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11098,Active,1868918,CHEMBL920193,Antimicrobial activity against Pseudomonas aeruginosa 65.36-4 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11099,Active,1868929,CHEMBL920195,Antimicrobial activity against Pseudomonas aeruginosa 65.38-2 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11100,Active,1868939,CHEMBL912018,Antimicrobial activity against Pseudomonas aeruginosa 65.38-3 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11101,Active,1868948,CHEMBL912019,Antimicrobial activity against Pseudomonas aeruginosa 65.38-4 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11102,Active,1868964,CHEMBL920194,Antimicrobial activity against Pseudomonas aeruginosa 65.38-1 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11103,Active,1869018,CHEMBL912020,Antimicrobial activity against Pseudomonas aeruginosa 1A9 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11104,Active,1869029,CHEMBL912021,Antimicrobial activity against Pseudomonas aeruginosa 1B9 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11105,Active,1869121,CHEMBL912022,Antimicrobial activity against Pseudomonas aeruginosa 1C9 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11106,Active,1869128,CHEMBL913069,Antimicrobial activity against Pseudomonas aeruginosa 2A1 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11107,Active,1869145,CHEMBL913070,Antimicrobial activity against Pseudomonas aeruginosa 2C1 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11108,Active,1869148,CHEMBL913071,Antimicrobial activity against Pseudomonas aeruginosa 2A2 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11109,Active,1869159,CHEMBL913072,Antimicrobial activity against Pseudomonas aeruginosa 2C2 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11110,Active,1869169,CHEMBL913073,Antimicrobial activity against Pseudomonas aeruginosa 2A3 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11111,Active,1869180,CHEMBL913074,Antimicrobial activity against Pseudomonas aeruginosa 2A5 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11112,Active,1869231,CHEMBL913075,Antimicrobial activity against Pseudomonas aeruginosa 2B5 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11113,Active,1869245,CHEMBL913076,Antimicrobial activity against Pseudomonas aeruginosa 2A6 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11114,Active,1869257,CHEMBL913077,Antimicrobial activity against Pseudomonas aeruginosa 2F6 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11115,Active,1869269,CHEMBL913078,Antimicrobial activity against Pseudomonas aeruginosa 2A7 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11116,Active,1869280,CHEMBL913079,Antimicrobial activity against Pseudomonas aeruginosa 2A9 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11117,Active,1869283,CHEMBL913080,Antimicrobial activity against Pseudomonas aeruginosa 3B1 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11118,Active,1869294,CHEMBL913081,Antimicrobial activity against Pseudomonas aeruginosa 65.68-1 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11119,Active,1869305,CHEMBL913082,Antimicrobial activity against Pseudomonas aeruginosa 65.68-2 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11120,Active,1869329,CHEMBL913083,Antimicrobial activity against Pseudomonas aeruginosa 65.68-3 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11121,Active,1869345,CHEMBL913085,Antimicrobial activity against Pseudomonas aeruginosa 65.68-4 tracheal isolates from mechanically ventilated tuberculosis patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11122,Active,1869363,CHEMBL913086,Antimicrobial activity against Pseudomonas aeruginosa 2A5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11123,Active,1869373,CHEMBL914688,Antimicrobial activity against Pseudomonas aeruginosa 3D1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11124,Active,1869380,CHEMBL914689,Antimicrobial activity against Pseudomonas aeruginosa 3D10 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11125,Active,1869390,CHEMBL914690,Antimicrobial activity against Pseudomonas aeruginosa 3E2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11126,Active,1869412,CHEMBL914691,Antimicrobial activity against Pseudomonas aeruginosa 5F2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11127,Active,1869424,CHEMBL914692,Antimicrobial activity against Pseudomonas aeruginosa 5F8 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11128,Active,1869430,CHEMBL914693,Antimicrobial activity against Pseudomonas aeruginosa 5G3 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11129,Active,1869437,CHEMBL913084,Antimicrobial activity against Pseudomonas aeruginosa 5H6 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11130,Active,1869459,CHEMBL914694,Antimicrobial activity against Pseudomonas aeruginosa 8A2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11131,Active,1869465,CHEMBL914695,Antimicrobial activity against Pseudomonas aeruginosa 8A12 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11132,Active,1869471,CHEMBL914696,Antimicrobial activity against Pseudomonas aeruginosa 8C4 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11133,Active,1869504,CHEMBL914697,Antimicrobial activity against Pseudomonas aeruginosa 8B11 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11134,Active,1869510,CHEMBL914698,Antimicrobial activity against Pseudomonas aeruginosa 9A1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11135,Active,1869516,CHEMBL914699,Antimicrobial activity against Pseudomonas aeruginosa 9A3 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11136,Active,1869522,CHEMBL914700,Antimicrobial activity against Pseudomonas aeruginosa 9A7 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11137,Active,1869528,CHEMBL914701,Antimicrobial activity against Pseudomonas aeruginosa 9A10 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11138,Active,1869561,CHEMBL914702,Antimicrobial activity against Pseudomonas aeruginosa 9B2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11139,Active,1869567,CHEMBL914703,Antimicrobial activity against Pseudomonas aeruginosa 9B5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11140,Active,1869573,CHEMBL914704,Antimicrobial activity against Pseudomonas aeruginosa 10A6 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11141,Active,1869585,CHEMBL914705,Antimicrobial activity against Pseudomonas aeruginosa 10A9 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11142,Active,1869591,CHEMBL914706,Antimicrobial activity against Pseudomonas aeruginosa 10B1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11143,Active,1869597,CHEMBL914707,Antimicrobial activity against Pseudomonas aeruginosa 10B3 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11144,Active,1869603,CHEMBL914708,Antimicrobial activity against Pseudomonas aeruginosa 12A3 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11145,Active,1869609,CHEMBL914136,Antimicrobial activity against Pseudomonas aeruginosa 12A7 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11146,Active,1869620,CHEMBL914137,Antimicrobial activity against Pseudomonas aeruginosa 12B2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11147,Active,1869641,CHEMBL913065,Antimicrobial activity against Pseudomonas aeruginosa 13D11 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11148,Active,1869647,CHEMBL913066,Antimicrobial activity against Pseudomonas aeruginosa 13E1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11149,Not Active,1869653,CHEMBL913067,Antimicrobial activity against Pseudomonas aeruginosa 15G2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11150,Active,1869676,CHEMBL914141,Antimicrobial activity against Pseudomonas aeruginosa 15H5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11151,Active,1869688,CHEMBL914143,Antimicrobial activity against Pseudomonas aeruginosa 16D5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11152,Active,1869700,CHEMBL914145,Antimicrobial activity against Pseudomonas aeruginosa 19B3 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11153,Active,1869707,CHEMBL914146,Antimicrobial activity against Pseudomonas aeruginosa 19B6 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11154,Active,1869740,CHEMBL914148,Antimicrobial activity against Pseudomonas aeruginosa 19C5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11155,Active,1869747,CHEMBL914149,Antimicrobial activity against Pseudomonas aeruginosa 19C7 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11156,Not Active,1869759,CHEMBL914151,Antimicrobial activity against Pseudomonas aeruginosa 19D9 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11157,Active,1869778,CHEMBL915645,Antimicrobial activity against Pseudomonas aeruginosa 19E2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11158,Active,1869791,CHEMBL915647,Antimicrobial activity against Pseudomonas aeruginosa 19E9 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11159,Active,1869815,CHEMBL915650,Antimicrobial activity against Pseudomonas aeruginosa 22D2 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11160,Active,1869825,CHEMBL915651,Antimicrobial activity against Pseudomonas aeruginosa 22D6 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11161,Active,1869831,CHEMBL915652,Antimicrobial activity against Pseudomonas aeruginosa 22D9 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11162,Active,1869840,CHEMBL915654,Antimicrobial activity against Pseudomonas aeruginosa 22E3 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11163,Active,1869846,CHEMBL915655,Antimicrobial activity against Pseudomonas aeruginosa 22C5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11164,Active,1869853,CHEMBL915656,Antimicrobial activity against Pseudomonas aeruginosa 24D1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11165,Not Active,1869861,CHEMBL915657,Antimicrobial activity against Pseudomonas aeruginosa 24D5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11166,Active,1869881,CHEMBL915660,Antimicrobial activity against Pseudomonas aeruginosa 24E5 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11167,Active,1869898,CHEMBL915663,Antimicrobial activity against Pseudomonas aeruginosa 24F4 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11168,Active,1869902,CHEMBL915064,Antimicrobial activity against Pseudomonas aeruginosa 24G1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11169,Active,1869909,CHEMBL915065,Antimicrobial activity against Pseudomonas aeruginosa 29F6 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11170,Active,1869918,CHEMBL915066,Antimicrobial activity against Pseudomonas aeruginosa 29G6 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11171,Active,1869925,CHEMBL915067,Antimicrobial activity against Pseudomonas aeruginosa 29G7 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11172,Active,1869931,CHEMBL915068,Antimicrobial activity against Pseudomonas aeruginosa 29G8 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11173,Active,1869937,CHEMBL915068,Antimicrobial activity against Pseudomonas aeruginosa 29G8 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11174,Not Active,1869944,CHEMBL915069,Antimicrobial activity against Pseudomonas aeruginosa 29H1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11175,Active,1869952,CHEMBL915653,Antimicrobial activity against Pseudomonas aeruginosa 22E1 tracheal isolates from mechanically ventilated chronic respiratory insufficiency patient,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147101,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,634883,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
11176,,1879334,CHEMBL905613,Permeability coefficient through artificial membrane in presence of stirred water layer,A,BAO_0002808,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1143050,Bioorg Med Chem,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,637841,=,1,0,=,Papp,10^-6 cm/s,0.18,CHEMBL612558,,ADMET,,,Papp,10^-6 cm/s,,0.18
11177,Not Active,1917544,CHEMBL894357,Antibacterial activity against multidrug resistant Staphylococcus aureus 49589,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1148734,J Med Chem,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,654126,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
11178,Not Determined,1951950,CHEMBL893613,Inhibition of bacterial DNA gyrase,B,BAO_0000190,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147922,Bioorg Med Chem Lett,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,651100,,1,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
11179,Not Determined,1951979,CHEMBL893614,Inhibition of bacterial DNA topoisomerase 4,B,BAO_0000190,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147922,Bioorg Med Chem Lett,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,651100,,1,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
11180,Not Determined,1952051,CHEMBL893615,Antibacterial activity against Escherichia coli KL16,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147922,Bioorg Med Chem Lett,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,651100,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
11181,,1952773,CHEMBL893616,Antibacterial activity against Staphylococcus aureus ATCC 13709,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147922,Bioorg Med Chem Lett,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,651100,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
11182,Not Determined,1952817,CHEMBL893617,Antibacterial activity against Streptococcus pneumoniae ATCC 49619,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147922,Bioorg Med Chem Lett,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,651100,,1,0,,MIC,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,,,
11183,,1952907,CHEMBL893618,Antibacterial activity against quinolone susceptible methicillin resistant Staphylococcus aureus OC2878,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147922,Bioorg Med Chem Lett,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,651100,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
11184,,1952928,CHEMBL893619,Antibacterial activity against ciprofloxacin resistant methicillin resistant Staphylococcus aureus OC3946,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147922,Bioorg Med Chem Lett,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,651100,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
11185,,1952953,CHEMBL893620,Antibacterial activity against ciprofloxacin resistant methicillin resistant Staphylococcus aureus OC4159,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147922,Bioorg Med Chem Lett,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,651100,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
11186,,1952976,CHEMBL892585,Antibacterial activity against ciprofloxacin resistant methicillin resistant Staphylococcus aureus OC4222,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147922,Bioorg Med Chem Lett,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,651100,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
11187,,1952992,CHEMBL892586,Antibacterial activity against ciprofloxacin resistant methicillin resistant Staphylococcus aureus OC5273,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1147922,Bioorg Med Chem Lett,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,651100,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
11188,,2021603,CHEMBL903530,Antimicrobial activity against fluoroquinolone-resistant Staphylococcus aureus SA1199B,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1139132,Bioorg Med Chem Lett,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,671729,=,1,1,=,MIC,nM,100000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,100.0
11189,,2052206,CHEMBL942812,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140570,Bioorg Med Chem Lett,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,680990,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
11190,,2052213,CHEMBL941868,Antibacterial activity against Escherichia coli ATCC 25922 by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140570,Bioorg Med Chem Lett,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,680990,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
11191,,2052220,CHEMBL941869,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140570,Bioorg Med Chem Lett,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,680990,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
11192,,2052228,CHEMBL941870,Antibacterial activity against Bacillus subtilis ATCC 6033 by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140570,Bioorg Med Chem Lett,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,680990,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,32.0
11193,,2052236,CHEMBL941871,Antibacterial activity against Staphylococcus aureus ATCC 25923 by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140570,Bioorg Med Chem Lett,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,680990,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
11194,,2052244,CHEMBL941872,Antibacterial activity against Streptococcus faecalis ATCC 29212 by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140570,Bioorg Med Chem Lett,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,680990,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,8.0
11195,,2063492,CHEMBL943135,Antibacterial activity against multidrug-resistant Staphylococcus aureus 1199B overexpressing NorA after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1141428,J Nat Prod,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,684993,=,1,1,=,MIC,nM,100000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,uM,UO_0000065,100.0
11196,,2126258,CHEMBL934997,Antibacterial activity against CTX-M group 1 enzyme producing Escherichia coli isolates by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702314,>,1,1,>,MIC50,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,8.0
11197,,2126259,CHEMBL934997,Antibacterial activity against CTX-M group 1 enzyme producing Escherichia coli isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702314,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,8.0
11198,,2126293,CHEMBL934998,Antibacterial activity against CTX-M group 1 enzyme producing Escherichia coli isolates assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,702314,=,1,0,=,Activity,%,98.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,98.0
11199,,2126311,CHEMBL934999,Antibacterial activity against CTX-M group 1 enzyme producing Escherichia coli isolates assessed as percent nonsusceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,702314,=,1,0,=,Activity,%,98.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,98.0
11200,,2126332,CHEMBL935000,Antibacterial activity against CTX-M group 9 enzyme producing Escherichia coli isolates by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702314,<=,1,1,<=,MIC50,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,2.0
11201,,2126333,CHEMBL935000,Antibacterial activity against CTX-M group 9 enzyme producing Escherichia coli isolates by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702314,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC90,ug ml-1,UO_0000274,8.0
11202,,2126369,CHEMBL935001,Antibacterial activity against CTX-M group 9 enzyme producing Escherichia coli isolates assessed as percent resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,702314,=,1,0,=,Activity,%,33.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,33.0
11203,,2126387,CHEMBL935002,Antibacterial activity against CTX-M group 9 enzyme producing Escherichia coli isolates assessed as percent nonsusceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1143815,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,702314,=,1,0,=,Activity,%,33.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,33.0
11204,,2127974,CHEMBL935952,Antibacterial activity against Escherichia coli K12 PhoU wild type W3110 after 16 hrs by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703979,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
11205,,2127975,CHEMBL935952,Antibacterial activity against Escherichia coli K12 PhoU wild type W3110 after 16 hrs by serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703979,=,1,0,=,MBC,ug ml-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,1.0
11206,,2127978,CHEMBL935953,Antibacterial activity against Escherichia coli K12 mutant JHU313 after 16 hrs by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703979,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
11207,,2127979,CHEMBL935953,Antibacterial activity against Escherichia coli K12 mutant JHU313 after 16 hrs by serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703979,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.5
11208,,2127982,CHEMBL935954,Antibacterial activity against Escherichia coli K12 mutant JHU313 containing plasmid PhoU after 16 hrs by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703979,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
11209,,2127983,CHEMBL935954,Antibacterial activity against Escherichia coli K12 mutant JHU313 containing plasmid PhoU after 16 hrs by serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703979,=,1,0,=,MBC,ug ml-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,1.0
11210,,2127986,CHEMBL935955,Antibacterial activity against Escherichia coli K12 mutant JHU313 containing plasmid vector after 16 hrs by serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703979,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
11211,,2127987,CHEMBL935955,Antibacterial activity against Escherichia coli K12 mutant JHU313 containing plasmid vector after 16 hrs by serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703979,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.5
11212,,2128030,CHEMBL935279,Antibacterial activity against Escherichia coli K12 PhoU wild type W3110 at 4 ug/ml after 48 hrs by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Millimolar,703979,=,1,0,=,IZ,mM,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mM,UO_0000063,32.0
11213,,2128031,CHEMBL935280,Antibacterial activity against Escherichia coli K12 mutant JHU313 at 4 ug/ml after 48 hrs by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Millimolar,703979,=,1,0,=,IZ,mM,37.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mM,UO_0000063,37.0
11214,,2128032,CHEMBL935281,Antibacterial activity against Escherichia coli K12 mutant JHU313 containing plasmid PhoU at 4 ug/ml after 48 hrs by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Millimolar,703979,=,1,0,=,IZ,mM,36.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mM,UO_0000063,36.0
11215,,2128033,CHEMBL936145,Antibacterial activity against Escherichia coli K12 mutant JHU313 containing plasmid vector at 4 ug/ml after 48 hrs by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Millimolar,703979,=,1,0,=,IZ,mM,44.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mM,UO_0000063,44.0
11216,,2128034,CHEMBL935166,Antibacterial activity against Escherichia coli K12 PhoU wild type W3110 at 2 ug/ml after 48 hrs by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Millimolar,703979,=,1,0,=,IZ,mM,30.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mM,UO_0000063,30.0
11217,,2128035,CHEMBL935167,Antibacterial activity against Escherichia coli K12 mutant JHU313 at 2 ug/ml after 48 hrs by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Millimolar,703979,=,1,0,=,IZ,mM,34.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mM,UO_0000063,34.0
11218,,2128036,CHEMBL935168,Antibacterial activity against Escherichia coli K12 mutant JHU313 containing plasmid PhoU at 2 ug/ml after 48 hrs by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Millimolar,703979,=,1,0,=,IZ,mM,35.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mM,UO_0000063,35.0
11219,,2128037,CHEMBL936044,Antibacterial activity against Escherichia coli K12 mutant JHU313 containing plasmid vector at 2 ug/ml after 48 hrs by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Millimolar,703979,=,1,0,=,IZ,mM,40.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mM,UO_0000063,40.0
11220,,2128038,CHEMBL936045,Antibacterial activity against Escherichia coli K12 PhoU wild type W3110 at 0.5 ug/ml after 48 hrs by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Millimolar,703979,=,1,0,=,IZ,mM,27.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mM,UO_0000063,27.0
11221,,2128039,CHEMBL936046,Antibacterial activity against Escherichia coli K12 mutant JHU313 at 0.5 ug/ml after 48 hrs by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Millimolar,703979,=,1,0,=,IZ,mM,30.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mM,UO_0000063,30.0
11222,,2128040,CHEMBL936047,Antibacterial activity against Escherichia coli K12 mutant JHU313 containing plasmid PhoU at 0.5 ug/ml after 48 hrs by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Millimolar,703979,=,1,0,=,IZ,mM,31.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mM,UO_0000063,31.0
11223,,2128041,CHEMBL936048,Antibacterial activity against Escherichia coli K12 mutant JHU313 containing plasmid vector at 0.5 ug/ml after 48 hrs by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Millimolar,703979,=,1,0,=,IZ,mM,35.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mM,UO_0000063,35.0
11224,,2128042,CHEMBL936049,Antibacterial activity against Escherichia coli K12 PhoU wild type W3110 at 0.1 ug/ml after 48 hrs by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Millimolar,703979,=,1,0,=,IZ,mM,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mM,UO_0000063,24.0
11225,,2128043,CHEMBL936050,Antibacterial activity against Escherichia coli K12 mutant JHU313 at 0.1 ug/ml after 48 hrs by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Millimolar,703979,=,1,0,=,IZ,mM,28.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mM,UO_0000063,28.0
11226,,2128044,CHEMBL936051,Antibacterial activity against Escherichia coli K12 mutant JHU313 containing plasmid PhoU at 0.1 ug/ml after 48 hrs by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Millimolar,703979,=,1,0,=,IZ,mM,27.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mM,UO_0000063,27.0
11227,,2128045,CHEMBL936052,Antibacterial activity against Escherichia coli K12 mutant JHU313 containing plasmid vector at 0.1 ug/ml after 48 hrs by disc diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Millimolar,703979,=,1,0,=,IZ,mM,29.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mM,UO_0000063,29.0
11228,,2128046,CHEMBL951906,Antibacterial activity against Escherichia coli K12 PhoU wild type W3110 assessed as cell count in log phase at 3 ug/ml after 5 hrs,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,10^8/ml,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,10^8/ml,,1.0
11229,,2128047,CHEMBL951907,Antibacterial activity against Escherichia coli K12 PhoU wild type W3110 assessed as cell count in stationary phase at 3 ug/ml after 5 hrs,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,10^9/ml,5.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,10^9/ml,,5.0
11230,,2128048,CHEMBL951908,Antibacterial activity against Escherichia coli K12 containing PhoU mutant assessed as cell count in log phase at 3 ug/ml after 5 hrs,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,10^7/ml,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,10^7/ml,,2.0
11231,,2128049,CHEMBL951909,Antibacterial activity against Escherichia coli K12 containing PhoU mutant assessed as cell count in stationary phase at 3 ug/ml after 5 hrs,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,10^8/ml,3.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,10^8/ml,,3.0
11232,,2128050,CHEMBL951910,Antibacterial activity against Escherichia coli K12 containing deletion deltaphoU mutant assessed as cell count in log phase at 3 ug/ml after 5 hrs,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,10^7/ml,5.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,10^7/ml,,5.0
11233,,2128051,CHEMBL951911,Antibacterial activity against Escherichia coli K12 containing deletion deltaphoU mutant assessed as cell count in stationary phase at 3 ug/ml after 5 hrs,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,10^8/ml,6.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,10^8/ml,,6.0
11234,,2128052,CHEMBL951912,Antibacterial activity against Escherichia coli K12 PhoU wild type W3110 assessed as cell count in log phase at 3 ug/ml after 1 day,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,10^6/ml,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,10^6/ml,,4.0
11235,,2128053,CHEMBL934952,Antibacterial activity against Escherichia coli K12 PhoU wild type W3110 assessed as cell count in stationary phase at 3 ug/ml after 1 day,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,10^9/ml,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,10^9/ml,,4.0
11236,,2128054,CHEMBL934953,Antibacterial activity against Escherichia coli K12 containing PhoU mutant assessed as cell count in log phase at 3 ug/ml after 1 day,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,10^5/ml,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,10^5/ml,,4.0
11237,,2128055,CHEMBL934954,Antibacterial activity against Escherichia coli K12 containing PhoU mutant assessed as cell count in stationary phase at 3 ug/ml after 1 day,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,10^7/ml,4.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,10^7/ml,,4.5
11238,,2128056,CHEMBL934955,Antibacterial activity against Escherichia coli K12 containing deletion deltaphoU mutant assessed as cell count in log phase at 3 ug/ml after 1 day,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,10^6/ml,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,10^6/ml,,1.0
11239,,2128057,CHEMBL934956,Antibacterial activity against Escherichia coli K12 containing deletion deltaphoU mutant assessed as cell count in stationary phase at 3 ug/ml after 1 day,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,10^8/ml,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,10^8/ml,,2.0
11240,,2128058,CHEMBL934957,Antibacterial activity against Escherichia coli K12 PhoU wild type W3110 assessed as cell count in log phase at 3 ug/ml after 3 days,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,10^4/ml,5.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,10^4/ml,,5.0
11241,,2128059,CHEMBL934958,Antibacterial activity against Escherichia coli K12 PhoU wild type W3110 assessed as cell count in stationary phase at 3 ug/ml after 3 days,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,10^8/ml,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,10^8/ml,,1.0
11242,,2128060,CHEMBL934959,Antibacterial activity against Escherichia coli K12 containing PhoU mutant assessed as cell count in log phase at 3 ug/ml after 3 days,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,/ml,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,/ml,,0.0
11243,,2128061,CHEMBL934960,Antibacterial activity against Escherichia coli K12 containing PhoU mutant assessed as cell count in stationary phase at 3 ug/ml after 3 days,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,10^5/ml,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,10^5/ml,,2.0
11244,,2128062,CHEMBL934962,Antibacterial activity against Escherichia coli K12 containing deletion deltaphoU mutant assessed as cell count in stationary phase at 3 ug/ml after 3 days,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,10^5/ml,3.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,10^5/ml,,3.0
11245,,2128063,CHEMBL934963,Antibacterial activity against Escherichia coli K12 PhoU wild type W3110 assessed as cell count in log phase at 3 ug/ml after 5 days,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,10^2/ml,7.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,10^2/ml,,7.0
11246,,2128064,CHEMBL934964,Antibacterial activity against Escherichia coli K12 PhoU wild type W3110 assessed as cell count in stationary phase at 3 ug/ml after 5 days,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,10^6/ml,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,10^6/ml,,4.0
11247,,2128065,CHEMBL935817,Antibacterial activity against Escherichia coli K12 PhoU wild type W3110 assessed as cell count in stationary phase at 3 ug/ml after 1 week,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,10^4/ml,1.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,10^4/ml,,1.5
11248,,2128066,CHEMBL952017,Antibacterial activity against Escherichia coli K12 PhoU wild type W3110 assessed as cell count in log phase at 3 ug/ml after 10 days,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,10^2/ml,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,10^2/ml,,2.0
11249,,2128067,CHEMBL934961,Antibacterial activity against Escherichia coli K12 containing deletion deltaphoU mutant assessed as cell count in log phase at 3 ug/ml after 3 days,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,/ml,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,/ml,,0.0
11250,,2128068,CHEMBL934965,Antibacterial activity against Escherichia coli K12 containing PhoU mutant assessed as cell count in log phase at 3 ug/ml after 5 days,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,/ml,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,/ml,,0.0
11251,,2128069,CHEMBL935813,Antibacterial activity against Escherichia coli K12 containing PhoU mutant assessed as cell count in stationary phase at 3 ug/ml after 5 days,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,/ml,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,/ml,,0.0
11252,,2128070,CHEMBL935814,Antibacterial activity against Escherichia coli K12 containing deletion deltaphoU mutant assessed as cell count in log phase at 3 ug/ml after 5 days,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,/ml,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,/ml,,0.0
11253,,2128071,CHEMBL935815,Antibacterial activity against Escherichia coli K12 containing deletion deltaphoU mutant assessed as cell count in stationary phase at 3 ug/ml after 5 days,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,/ml,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,/ml,,0.0
11254,,2128072,CHEMBL935816,Antibacterial activity against Escherichia coli K12 PhoU wild type W3110 assessed as cell count in log phase at 3 ug/ml after 1 week,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,/ml,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,/ml,,0.0
11255,,2128073,CHEMBL935818,Antibacterial activity against Escherichia coli K12 containing PhoU mutant assessed as cell count in log phase at 3 ug/ml after 1 week,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,/ml,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,/ml,,0.0
11256,,2128074,CHEMBL935819,Antibacterial activity against Escherichia coli K12 containing PhoU mutant assessed as cell count in stationary phase at 3 ug/ml after 1 week,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,/ml,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,/ml,,0.0
11257,,2128075,CHEMBL935820,Antibacterial activity against Escherichia coli K12 containing deletion deltaphoU mutant assessed as cell count in log phase at 3 ug/ml after 1 week,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,/ml,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,/ml,,0.0
11258,,2128076,CHEMBL952015,Antibacterial activity against Escherichia coli K12 containing deletion deltaphoU mutant assessed as cell count in stationary phase at 3 ug/ml after 1 week,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,/ml,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,/ml,,0.0
11259,,2128077,CHEMBL952016,Antibacterial activity against Escherichia coli K12 PhoU wild type W3110 assessed as cell count in log phase at 3 ug/ml after 10 days,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,/ml,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,/ml,,0.0
11260,,2128078,CHEMBL952018,Antibacterial activity against Escherichia coli K12 containing PhoU mutant assessed as cell count in log phase at 3 ug/ml after 10 days,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,/ml,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,/ml,,0.0
11261,,2128079,CHEMBL952019,Antibacterial activity against Escherichia coli K12 containing PhoU mutant assessed as cell count in stationary phase at 3 ug/ml after 10 days,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,/ml,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,/ml,,0.0
11262,,2128080,CHEMBL952020,Antibacterial activity against Escherichia coli K12 containing deletion deltaphoU mutant assessed as cell count in log phase at 3 ug/ml after 10 days,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,/ml,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,/ml,,0.0
11263,,2128081,CHEMBL952021,Antibacterial activity against Escherichia coli K12 containing deletion deltaphoU mutant assessed as cell count in stationary phase at 3 ug/ml after 10 days,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1145465,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,703979,=,1,0,=,CFU,/ml,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,CFU,/ml,,0.0
11264,,2216647,CHEMBL974059,Inhibition of Escherichia coli H560 DNA gyrase,B,BAO_0000190,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1149878,Bioorg Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,767637,=,1,1,=,IC50,ug.mL-1,1.0,CHEMBL612545,,Unchecked,,,IC50,ug ml-1,UO_0000274,1.0
11265,,2229944,CHEMBL998793,Antibacterial activity against methicillin-resistant Staphylococcus aureus SA1199B after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1156638,J Nat Prod,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,796114,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
11266,,2229959,CHEMBL999559,Antibacterial activity against macrolide-resistant Staphylococcus aureus RN4220 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1156638,J Nat Prod,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,796114,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
11267,,2229974,CHEMBL999560,Antibacterial activity against tetracycline-resistant Staphylococcus aureus XU212 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1156638,J Nat Prod,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,796114,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
11268,,2229990,CHEMBL999561,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 25923 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1156638,J Nat Prod,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,796114,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
11269,,2230006,CHEMBL999562,Antibacterial activity against epidemic methicillin-resistant Staphylococcus aureus 15 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1156638,J Nat Prod,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,796114,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
11270,,2230022,CHEMBL999563,Antibacterial activity against epidemic methicillin-resistant Staphylococcus aureus 16 after 18 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1156638,J Nat Prod,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,796114,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
11271,,2296089,CHEMBL1025121,Antimicrobial activity against Staphylococcus aureus after 24 hrs by agar diffusion technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137764,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,812324,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
11272,,2296092,CHEMBL1025119,Antimicrobial activity against Escherichia coli after 24 hrs by agar diffusion technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137764,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,812324,=,1,1,=,MIC,ug.mL-1,14.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,14.0
11273,,2296100,CHEMBL1025118,Antimicrobial activity against Pseudomonas aeruginosa after 24 hrs by agar diffusion technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137764,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,812324,=,1,1,=,MIC,ug.mL-1,9.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,9.0
11274,,2296102,CHEMBL1025120,Antimicrobial activity against Klebsiella pneumoniae after 24 hrs by agar diffusion technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137764,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,812324,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
11275,,2296171,CHEMBL1025117,Antimicrobial activity against Staphylococcus aureus at 512 ug/ml after 24 hrs by agar diffusion technique,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137764,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,812324,=,1,1,=,IZ,mm,20.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,20.0
11276,,2296172,CHEMBL1025102,Antimicrobial activity against Pseudomonas aeruginosa at 512 ug/ml after 24 hrs by agar diffusion technique,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137764,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,812324,=,1,1,=,IZ,mm,20.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,20.0
11277,,2296173,CHEMBL1025107,Antimicrobial activity against Escherichia coli at 512 ug/ml after 24 hrs by agar diffusion technique,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137764,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,812324,=,1,1,=,IZ,mm,19.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,19.0
11278,,2296182,CHEMBL1025101,Antimicrobial activity against Pseudomonas aeruginosa at 128 ug/ml after 24 hrs by agar diffusion technique,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137764,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,812324,=,1,1,=,IZ,mm,15.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,15.0
11279,,2296193,CHEMBL1025112,Antimicrobial activity against Klebsiella pneumoniae at 512 ug/ml after 24 hrs by agar diffusion technique,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137764,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,812324,=,1,1,=,IZ,mm,12.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,DIZ,mm,UO_0000016,12.0
11280,,2296221,CHEMBL1025111,Antimicrobial activity against Klebsiella pneumoniae at 128 ug/ml after 24 hrs by agar diffusion technique,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137764,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,812324,=,1,1,=,IZ,mm,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,DIZ,mm,UO_0000016,8.0
11281,,2296232,CHEMBL1025106,Antimicrobial activity against Escherichia coli at 128 ug/ml after 24 hrs by agar diffusion technique,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137764,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,812324,=,1,1,=,IZ,mm,6.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,6.0
11282,,2296236,CHEMBL1025110,Antimicrobial activity against Klebsiella pneumoniae at 64 ug/ml after 24 hrs by agar diffusion technique,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137764,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,812324,=,1,1,=,IZ,mm,5.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,DIZ,mm,UO_0000016,5.0
11283,,2296237,CHEMBL1024281,Antimicrobial activity against Pseudomonas aeruginosa at 64 ug/ml after 24 hrs by agar diffusion technique,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137764,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,812324,=,1,1,=,IZ,mm,5.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,5.0
11284,,2296244,CHEMBL1025105,Antimicrobial activity against Escherichia coli at 64 ug/ml after 24 hrs by agar diffusion technique,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137764,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,812324,=,1,1,=,IZ,mm,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,4.0
11285,,2296257,CHEMBL1025116,Antimicrobial activity against Staphylococcus aureus at 128 ug/ml after 24 hrs by agar diffusion technique,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137764,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,812324,=,1,1,=,IZ,mm,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,3.0
11286,,2296264,CHEMBL1024280,Antimicrobial activity against Pseudomonas aeruginosa at 16 ug/ml after 24 hrs by agar diffusion technique,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137764,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,812324,=,1,1,=,IZ,mm,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,2.0
11287,,2296717,CHEMBL1025115,Antimicrobial activity against Staphylococcus aureus at 64 ug/ml after 24 hrs by agar diffusion technique,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137764,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,812324,=,1,1,=,IZ,mm,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,0.0
11288,,2296718,CHEMBL1025114,Antimicrobial activity against Staphylococcus aureus at 16 ug/ml after 24 hrs by agar diffusion technique,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137764,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,812324,=,1,1,=,IZ,mm,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,0.0
11289,,2296719,CHEMBL1025113,Antimicrobial activity against Staphylococcus aureus at 4 ug/ml after 24 hrs by agar diffusion technique,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137764,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,812324,=,1,1,=,IZ,mm,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,DIZ,mm,UO_0000016,0.0
11290,,2296720,CHEMBL1025109,Antimicrobial activity against Klebsiella pneumoniae at 16 ug/ml after 24 hrs by agar diffusion technique,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137764,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,812324,=,1,1,=,IZ,mm,0.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,DIZ,mm,UO_0000016,0.0
11291,,2296721,CHEMBL1025108,Antimicrobial activity against Klebsiella pneumoniae at 4 ug/ml after 24 hrs by agar diffusion technique,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137764,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,812324,=,1,1,=,IZ,mm,0.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,DIZ,mm,UO_0000016,0.0
11292,,2296722,CHEMBL1025104,Antimicrobial activity against Escherichia coli at 16 ug/ml after 24 hrs by agar diffusion technique,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137764,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,812324,=,1,1,=,IZ,mm,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,0.0
11293,,2296723,CHEMBL1025103,Antimicrobial activity against Escherichia coli at 4 ug/ml after 24 hrs by agar diffusion technique,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137764,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,812324,=,1,1,=,IZ,mm,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,DIZ,mm,UO_0000016,0.0
11294,,2296724,CHEMBL1024279,Antimicrobial activity against Pseudomonas aeruginosa at 4 ug/ml after 24 hrs by agar diffusion technique,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137764,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,812324,=,1,1,=,IZ,mm,0.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,DIZ,mm,UO_0000016,0.0
11295,,2345530,CHEMBL955639,Antimicrobial activity against Vibrio splendidus 12B01 expressing plasmid-mediated QnrS-like quinolone resistance determinants,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793428,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613176,Vibrio splendidus,Vibrio splendidus,29497.0,,MIC,ug ml-1,UO_0000274,0.25
11296,,2345531,CHEMBL955640,Antimicrobial activity against Vibrio splendidus LGP32 expressing plasmid-mediated QnrS-like quinolone resistance determinants,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793428,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL613176,Vibrio splendidus,Vibrio splendidus,29497.0,,MIC,ug ml-1,UO_0000274,0.5
11297,,2345532,CHEMBL956419,Antimicrobial activity against Escherichia coli TOP10 harbouring pVS1 expressing quinolone resistant Vibrio splendidus 12B01 QnrVS1 gene,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793428,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
11298,,2345533,CHEMBL956420,Antimicrobial activity against Escherichia coli TOP10 harbouring pVS2 expressing quinolone resistant Vibrio splendidus LGP32 QnrVS2 gene,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793428,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
11299,,2345534,CHEMBL956421,Antimicrobial activity against Escherichia coli TOP10 harbouring pS1 plasmid expressing quinolone resistant QnrS1 gene,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793428,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
11300,,2345535,CHEMBL956422,Antimicrobial activity against Escherichia coli TOP10 harbouring pS2 plasmid expressing quinolone resistant QnrS2 gene,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793428,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
11301,,2345536,CHEMBL956423,Antimicrobial activity against Escherichia coli TOP10 harbouring p0 plasmid expressing pCR-BluntII-TOPO,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793428,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
11302,,2345537,CHEMBL956424,Antimicrobial activity against Escherichia coli TOP10,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1150794,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793428,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
11303,,2347393,CHEMBL957902,Antibacterial activity against Escherichia coli C600Rif by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793354,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.064
11304,,2347394,CHEMBL957904,Antibacterial activity against Escherichia coli C600Rif in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793354,=,1,1,=,MIC,ug.mL-1,0.047,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.047
11305,,2347395,CHEMBL957905,Antibacterial activity against Escherichia coli C600Rif in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793354,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.032
11306,,2347396,CHEMBL957906,Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793354,=,1,1,=,MIC,ug.mL-1,1.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.5
11307,,2347397,CHEMBL957907,Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793354,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.064
11308,,2347398,CHEMBL957908,Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793354,=,1,1,=,MIC,ug.mL-1,0.047,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.047
11309,,2347399,CHEMBL957909,Antibacterial activity against Escherichia coli TOP10 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793354,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.032
11310,,2347400,CHEMBL957910,Antibacterial activity against Escherichia coli TOP10 in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793354,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
11311,,2347401,CHEMBL957911,Antibacterial activity against Escherichia coli TOP10 in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793354,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
11312,,2347402,CHEMBL957912,Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793354,=,1,1,=,MIC,ug.mL-1,0.38,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.38
11313,,2347403,CHEMBL957913,Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793354,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
11314,,2347404,CHEMBL957914,Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793354,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
11315,,2347405,CHEMBL957915,Antibacterial activity against Escherichia coli TOP10 containing pAT851 plasmid by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793354,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.19
11316,,2347406,CHEMBL957916,Antibacterial activity against Escherichia coli TOP10 containing pAT851 in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793354,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
11317,,2347407,CHEMBL957917,Antibacterial activity against Escherichia coli TOP10 containing pAT851 in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1156417,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793354,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
11318,,2348485,CHEMBL960520,Antibacterial activity against Enterobacter cloacae S1 isolate expressing quinolone resistance determinant QnrB4 by E-test,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1157376,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792943,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,32.0
11319,,2348490,CHEMBL960519,Antibacterial activity against Escherichia coli TOP10 containing pS1A plasmid expressing quinolone resistance determinant QnrB4 by E-test,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1157376,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792943,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
11320,,2348491,CHEMBL960518,Antibacterial activity against Escherichia coli TOP10 containing pS1B plasmid expressing quinolone resistance determinant QnrS1 by E-test,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1157376,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792943,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
11321,,2348493,CHEMBL960517,Antibacterial activity against Escherichia coli TOP10 by E-test,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1157376,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792943,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
11322,,2364598,CHEMBL994142,Antifungal activity against Rhizoctonia bataticola at 100 ug/mL after 48 hrs by cup-plate method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140196,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,773476,=,1,1,=,IZ,mm,260.0,CHEMBL613221,Macrophomina phaseolina,Macrophomina phaseolina,35725.0,,IZ,mm,UO_0000016,260.0
11323,,2364619,CHEMBL994143,Antifungal activity against Rhizoctonia bataticola at 50 ug/mL after 48 hrs by cup-plate method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140196,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,773476,=,1,1,=,IZ,mm,210.0,CHEMBL613221,Macrophomina phaseolina,Macrophomina phaseolina,35725.0,,IZ,mm,UO_0000016,210.0
11324,,2364640,CHEMBL994144,Antifungal activity against Rhizoctonia bataticola at 25 ug/mL after 48 hrs by cup-plate method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140196,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,773476,=,1,1,=,IZ,mm,160.0,CHEMBL613221,Macrophomina phaseolina,Macrophomina phaseolina,35725.0,,IZ,mm,UO_0000016,160.0
11325,,2364661,CHEMBL994133,Antibacterial activity against Escherichia coli at 100 ug/mL after 48 hrs by cup-plate method,F,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140196,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,773476,=,1,1,=,Inhibition,%,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,INH,%,UO_0000187,100.0
11326,,2364681,CHEMBL994134,Antibacterial activity against Escherichia coli at 50 ug/mL after 48 hrs by cup-plate method,F,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140196,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,773476,=,1,1,=,Inhibition,%,220.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,INH,%,UO_0000187,220.0
11327,,2364695,CHEMBL994135,Antibacterial activity against Escherichia coli at 25 ug/mL after 48 hrs by cup-plate method,F,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140196,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,773476,=,1,1,=,Inhibition,%,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,INH,%,UO_0000187,100.0
11328,,2364715,CHEMBL994136,Antibacterial activity against Bacillus cirrhosis at 100 ug/mL after 48 hrs by cup-plate method,F,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140196,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,773476,=,1,1,=,Inhibition,%,100.0,CHEMBL612428,Bacillus,Bacillus,1386.0,,INH,%,UO_0000187,100.0
11329,,2364735,CHEMBL994137,Antibacterial activity against Bacillus cirrhosis at 50 ug/mL after 48 hrs by cup-plate method,F,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140196,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,773476,=,1,1,=,Inhibition,%,100.0,CHEMBL612428,Bacillus,Bacillus,1386.0,,INH,%,UO_0000187,100.0
11330,,2364749,CHEMBL994138,Antibacterial activity against Bacillus cirrhosis at 25 ug/mL after 48 hrs by cup-plate method,F,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140196,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,773476,=,1,1,=,Inhibition,%,100.0,CHEMBL612428,Bacillus,Bacillus,1386.0,,INH,%,UO_0000187,100.0
11331,,2364769,CHEMBL994139,Antifungal activity against Aspergillus niger at 100 ug/mL after 48 hrs by cup-plate method,F,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140196,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,773476,=,1,1,=,Inhibition,%,100.0,CHEMBL358,Aspergillus niger,Aspergillus niger,5061.0,,INH,%,UO_0000187,100.0
11332,,2364789,CHEMBL994140,Antifungal activity against Aspergillus niger at 50 ug/mL after 48 hrs by cup-plate method,F,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140196,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,773476,=,1,1,=,Inhibition,%,100.0,CHEMBL358,Aspergillus niger,Aspergillus niger,5061.0,,INH,%,UO_0000187,100.0
11333,,2364802,CHEMBL994141,Antifungal activity against Aspergillus niger at 25 ug/mL after 48 hrs by cup-plate method,F,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140196,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,773476,=,1,1,=,Inhibition,%,100.0,CHEMBL358,Aspergillus niger,Aspergillus niger,5061.0,,INH,%,UO_0000187,100.0
11334,,2364822,CHEMBL994142,Antifungal activity against Rhizoctonia bataticola at 100 ug/mL after 48 hrs by cup-plate method,F,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140196,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,773476,=,1,1,=,Inhibition,%,100.0,CHEMBL613221,Macrophomina phaseolina,Macrophomina phaseolina,35725.0,,INH,%,UO_0000187,100.0
11335,,2364842,CHEMBL994143,Antifungal activity against Rhizoctonia bataticola at 50 ug/mL after 48 hrs by cup-plate method,F,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140196,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,773476,=,1,1,=,Inhibition,%,100.0,CHEMBL613221,Macrophomina phaseolina,Macrophomina phaseolina,35725.0,,INH,%,UO_0000187,100.0
11336,,2364853,CHEMBL994144,Antifungal activity against Rhizoctonia bataticola at 25 ug/mL after 48 hrs by cup-plate method,F,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140196,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,773476,=,1,1,=,Inhibition,%,100.0,CHEMBL613221,Macrophomina phaseolina,Macrophomina phaseolina,35725.0,,INH,%,UO_0000187,100.0
11337,,2374651,CHEMBL994133,Antibacterial activity against Escherichia coli at 100 ug/mL after 48 hrs by cup-plate method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140196,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,773476,=,1,1,=,IZ,mm,250.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,250.0
11338,,2374672,CHEMBL994134,Antibacterial activity against Escherichia coli at 50 ug/mL after 48 hrs by cup-plate method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140196,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,773476,=,1,1,=,IZ,mm,220.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,220.0
11339,,2374693,CHEMBL994135,Antibacterial activity against Escherichia coli at 25 ug/mL after 48 hrs by cup-plate method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140196,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,773476,=,1,1,=,IZ,mm,160.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,160.0
11340,,2374714,CHEMBL994136,Antibacterial activity against Bacillus cirrhosis at 100 ug/mL after 48 hrs by cup-plate method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140196,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,773476,=,1,1,=,IZ,mm,240.0,CHEMBL612428,Bacillus,Bacillus,1386.0,,IZ,mm,UO_0000016,240.0
11341,,2374735,CHEMBL994137,Antibacterial activity against Bacillus cirrhosis at 50 ug/mL after 48 hrs by cup-plate method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140196,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,773476,=,1,1,=,IZ,mm,200.0,CHEMBL612428,Bacillus,Bacillus,1386.0,,IZ,mm,UO_0000016,200.0
11342,,2374756,CHEMBL994138,Antibacterial activity against Bacillus cirrhosis at 25 ug/mL after 48 hrs by cup-plate method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140196,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,773476,=,1,1,=,IZ,mm,160.0,CHEMBL612428,Bacillus,Bacillus,1386.0,,IZ,mm,UO_0000016,160.0
11343,,2374777,CHEMBL994139,Antifungal activity against Aspergillus niger at 100 ug/mL after 48 hrs by cup-plate method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140196,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,773476,=,1,1,=,IZ,mm,240.0,CHEMBL358,Aspergillus niger,Aspergillus niger,5061.0,,IZ,mm,UO_0000016,240.0
11344,,2374798,CHEMBL994140,Antifungal activity against Aspergillus niger at 50 ug/mL after 48 hrs by cup-plate method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140196,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,773476,=,1,1,=,IZ,mm,200.0,CHEMBL358,Aspergillus niger,Aspergillus niger,5061.0,,IZ,mm,UO_0000016,200.0
11345,,2374819,CHEMBL994141,Antifungal activity against Aspergillus niger at 25 ug/mL after 48 hrs by cup-plate method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140196,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,773476,=,1,1,=,IZ,mm,160.0,CHEMBL358,Aspergillus niger,Aspergillus niger,5061.0,,IZ,mm,UO_0000016,160.0
11346,,2463023,CHEMBL965372,Antimicrobial activity against Staphylococcus aureus ATCC 25923,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1157407,J Nat Prod,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792912,>,1,1,>,MIC,ug.mL-1,512.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,512.0
11347,,2463028,CHEMBL965371,Antimicrobial activity against methicillin-resistant Staphylococcus aureus XU212,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1157407,J Nat Prod,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792912,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,512.0
11348,,2463033,CHEMBL965376,Antimicrobial activity against epidemic methicillin-resistant Staphylococcus aureus 15 containing mecA gene,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1157407,J Nat Prod,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792912,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,256.0
11349,,2463039,CHEMBL965377,Antimicrobial activity against multidrug-resistant Staphylococcus aureus over expressing NorA MDR efflux pump,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1157407,J Nat Prod,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,792912,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
11350,,2485938,CHEMBL984434,Antimicrobial activity against Pseudomonas aeruginosa,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1144182,Bioorg Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,772807,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
11351,,2487057,CHEMBL968935,Antibacterial activity against Staphylococcus aureus ATCC 11632 after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140971,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,728379,<,1,1,<,MIC,ug.mL-1,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,5.0
11352,,2487058,CHEMBL968936,Antibacterial activity against Streptococcus faecalis ATCC 14506 after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140971,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,728379,<,1,1,<,MIC,ug.mL-1,5.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,5.0
11353,,2487059,CHEMBL968937,Antibacterial activity against Bacillus subtilis ATCC 60511 after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140971,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,728379,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,1.0
11354,,2487060,CHEMBL968938,Antibacterial activity against Klebsiella pneumoniae ATCC 10031 after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140971,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,728379,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
11355,,2487061,CHEMBL968939,Antibacterial activity against Escherichia coli ATCC 10536 after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140971,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,728379,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
11356,,2487062,CHEMBL968940,Antibacterial activity against Pseudomonas aeruginosa ATCC 10145 after 18 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1140971,Eur J Med Chem,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,728379,>,1,1,>,MIC,ug.mL-1,5.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,5.0
11357,,2494967,CHEMBL982495,Sensitivity of Staphylococcus aureus isolated from lactating Holstein bovine subclinical mastitis model at 5 ug/disk after 20 hrs,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154401,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,779195,>=,1,1,>=,IZ,mm,17.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,17.0
11358,,2494971,CHEMBL982500,Resistance of Staphylococcus aureus isolated from lactating Holstein bovine subclinical mastitis model at 5 ug/disk after 20 hrs,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154401,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,779195,<=,1,1,<=,IZ,mm,12.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,12.0
11359,,2494975,CHEMBL982500,Resistance of Staphylococcus aureus isolated from lactating Holstein bovine subclinical mastitis model at 5 ug/disk after 20 hrs,F,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154401,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,779195,=,1,0,=,Activity,%,75.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,75.0
11360,Active,2495128,CHEMBL1028824,Increase in ompX-lacZ expression in Escherichia coli deltaompX mutant assessed as increase in beta-galactosidase activity after 60 mins relative to control,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154405,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,779604,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
11361,Active,2495135,CHEMBL1028825,Increase in ompX-lacZ expression in Escherichia coli JM109 assessed as ompX upregulation after 60 mins relative to control,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154405,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,779604,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
11362,Active,2495142,CHEMBL1028826,Increase in ompX-lacZ expression in Escherichia coli JM109 assessed as increase in beta-galactosidase activity after 60 mins relative to control,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154405,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,779604,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
11363,Active,2495149,CHEMBL1028827,Increase in ompX-lacZ expression in Enterobacter aerogenes ATCC 15038 assessed as ompX upregulation after 60 mins relative to control,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154405,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,779604,,1,0,,Activity,,,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,Activity,,,
11364,Active,2495156,CHEMBL1028828,Increase in ompX-lacZ expression in Enterobacter aerogenes ATCC 15038 assessed as increase in beta-galactosidase activity after 60 mins relative to control,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154405,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,779604,,1,0,,Activity,,,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,Activity,,,
11365,,2495162,CHEMBL1028829,Increase in ompX-lacZ expression in marA-negative Escherichia coli CH164 mutant assessed as beta-galactosidase activity after 60 mins relative to control,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154405,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,779604,=,1,0,=,Activity,,1.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,1.5
11366,,2495168,CHEMBL1028832,Effect on ompF-lacZ fusion transcription in wild type Escherichia coli MC1061 assessed as percent decrease in Miller units of beta-galactosidase activity after 90 mins relative to control,F,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154405,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,779604,=,1,0,=,Activity,%,14.9,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,14.9
11367,,2495171,CHEMBL1028833,Effect on ompF-lacZ fusion transcription in wild type Escherichia coli MC1061 assessed as percent decrease in Miller units of beta-galactosidase activity after 120 mins relative to control,F,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154405,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,779604,=,1,0,=,Activity,%,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,24.0
11368,,2495176,CHEMBL1031342,Effect on ompF-lacZ fusion transcription in ompX-negative Escherichia coli mutant assessed as percent decrease in Miller units of beta-galactosidase activity after 90 mins relative to control,F,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154405,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,779604,=,1,0,=,Activity,%,18.6,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,18.6
11369,,2495179,CHEMBL1031343,Effect on ompF-lacZ fusion transcription in ompX-negative Escherichia coli mutant assessed as percent decrease in Miller units of beta-galactosidase activity after 120 mins relative to control,F,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154405,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,779604,=,1,0,=,Activity,%,19.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,19.2
11370,,2495182,CHEMBL1031344,Effect on ompF-lacZ fusion transcription in wild type Escherichia coli AG100 assessed as percent decrease in Miller units of beta-galactosidase activity after 60 mins relative to control,F,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154405,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,779604,=,1,0,=,Activity,%,13.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,13.2
11371,,2495187,CHEMBL1031346,Effect on ompF-lacZ fusion transcription in wild type Escherichia coli AG100 assessed as percent decrease in Miller units of beta-galactosidase activity after 120 mins relative to control,F,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154405,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,779604,=,1,0,=,Activity,%,8.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,8.2
11372,,2495199,CHEMBL1026338,Effect on ompF-lacZ fusion translation in wild type Escherichia coli MC1061 assessed as percent decrease in Miller units of beta-galactosidase activity after 90 mins relative to control,F,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154405,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,779604,=,1,0,=,Activity,%,27.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,27.1
11373,,2495203,CHEMBL1026339,Effect on ompF-lacZ fusion translation in wild type Escherichia coli MC1061 assessed as percent decrease in Miller units of beta-galactosidase activity after 120 mins relative to control,F,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154405,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,779604,=,1,0,=,Activity,%,27.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,27.5
11374,,2495209,CHEMBL1026341,Effect on ompF-lacZ fusion translation in ompX-negative Escherichia coli mutant assessed as percent decrease in Miller units of beta-galactosidase activity after 90 mins relative to control,F,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154405,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,779604,=,1,0,=,Activity,%,21.7,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,21.7
11375,,2495213,CHEMBL1026342,Effect on ompF-lacZ fusion translation in ompX-negative Escherichia coli mutant assessed as percent decrease in Miller units of beta-galactosidase activity after 120 mins relative to control,F,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154405,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,779604,=,1,0,=,Activity,%,22.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,22.0
11376,,2495217,CHEMBL1026343,Effect on ompF-lacZ fusion translation in wild type Escherichia coli AG100 assessed as percent decrease in Miller units of beta-galactosidase activity after 60 mins relative to control,F,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154405,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,779604,=,1,0,=,Activity,%,14.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,14.1
11377,,2495944,CHEMBL1028836,Effect on ompF-lacZ fusion translation in wild type Escherichia coli AG100 assessed as percent decrease in Miller units of beta-galactosidase activity after 120 mins relative to control,F,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154405,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,779604,=,1,0,=,Activity,%,16.6,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,16.6
11378,Active,2496146,CHEMBL1027143,Induction of Escherichia coli DNA topoisomerase 4-mediated negatively supercoiled Escherichia coli pBR322 DNA cleavage at 50 uM after 10 mins by gel electrophoresis,B,BAO_0000375,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154411,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,780045,,1,0,,Activity,,,CHEMBL612545,,Unchecked,,,Activity,,,
11379,Active,2496147,CHEMBL1027144,Induction of Staphylococcus aureus DNA topoisomerase 4-mediated negatively supercoiled Escherichia coli pBR322 DNA cleavage at 50 uM after 10 mins by gel electrophoresis,B,BAO_0000375,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154411,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,780045,,1,0,,Activity,,,CHEMBL612545,,Unchecked,,,Activity,,,
11380,Active,2496148,CHEMBL983304,Induction of Escherichia coli DNA gyrase-mediated negatively supercoiled Escherichia coli pBR322 DNA cleavage at 50 uM after 10 mins by gel electrophoresis,B,BAO_0000375,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154411,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,780045,,1,0,,Activity,,,CHEMBL612545,,Unchecked,,,Activity,,,
11381,Active,2496149,CHEMBL983305,Induction of Staphylococcus aureus DNA gyrase-mediated negatively supercoiled Escherichia coli pBR322 DNA cleavage at 50 uM after 10 mins by gel electrophoresis,B,BAO_0000375,BAO_0000223,protein complex format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154411,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,780045,,1,0,,Activity,,,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,Activity,,,
11382,,2496150,CHEMBL983307,Induction of Escherichia coli DNA gyrase-mediated negatively supercoiled Escherichia coli pBR322 DNA cleavage assessed as amount of linear DNA generated per unit amount of enzyme at 50 uM after 10 mins by gel electrophoresis,B,BAO_0000181,BAO_0000223,protein complex format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154411,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,780045,=,1,0,=,Activity,ng,0.39,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,Activity,ng,UO_0000024,0.39
11383,,2496151,CHEMBL983306,Induction of Escherichia coli DNA topoisomerase 4-mediated negatively supercoiled Escherichia coli pBR322 DNA cleavage assessed as amount of linear DNA generated per unit amount of enzyme at 50 uM after 10 mins by gel electrophoresis,B,BAO_0000181,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154411,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,780045,=,1,0,=,Activity,ng,0.53,CHEMBL612545,,Unchecked,,,Activity,ng,UO_0000024,0.53
11384,,2496152,CHEMBL983308,Induction of Staphylococcus aureus DNA topoisomerase 4-mediated negatively supercoiled Escherichia coli pBR322 DNA cleavage assessed as amount of linear DNA generated per unit amount of enzyme at 50 uM after 10 mins by gel electrophoresis,B,BAO_0000181,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154411,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,780045,=,1,0,=,Activity,ng,0.42,CHEMBL612545,,Unchecked,,,Activity,ng,UO_0000024,0.42
11385,,2496153,CHEMBL983309,Induction of Staphylococcus aureus DNA gyrase-mediated negatively supercoiled Escherichia coli pBR322 DNA cleavage assessed as amount of linear DNA generated per unit amount of enzyme at 50 uM after 10 mins by gel electrophoresis,B,BAO_0000181,BAO_0000223,protein complex format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154411,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,780045,=,1,0,=,Activity,ng,0.049,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,Activity,ng,UO_0000024,0.049
11386,,2496154,CHEMBL983310,Induction of Escherichia coli DNA gyrase-mediated Escherichia coli pBR322 DNA cleavage assessed as ratio of drug-induced DNA cleavage to spontaneous DNA cleavage at 50 uM after 10 mins by gel electrophoresis,B,BAO_0000193,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154411,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,780045,=,1,0,=,Ratio,,68.4,CHEMBL612545,,Unchecked,,,Ratio,,,68.4
11387,,2496155,CHEMBL983311,Induction of Escherichia coli DNA topoisomerase 4-mediated Escherichia coli pBR322 DNA cleavage assessed as ratio of drug-induced DNA cleavage to spontaneous DNA cleavage at 50 uM after 10 mins by gel electrophoresis,B,BAO_0000193,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154411,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,780045,=,1,0,=,Ratio,,3.79,CHEMBL612545,,Unchecked,,,Ratio,,,3.79
11388,,2496156,CHEMBL983312,Induction of Staphylococcus aureus DNA gyrase-mediated Escherichia coli pBR322 DNA cleavage assessed as ratio of drug-induced DNA cleavage to spontaneous DNA cleavage at 50 uM after 10 mins by gel electrophoresis,B,BAO_0000193,BAO_0000223,protein complex format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154411,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,780045,=,1,0,=,Ratio,,10.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,Ratio,,,10.0
11389,,2496157,CHEMBL983313,Induction of Staphylococcus aureus DNA topoisomerase 4-mediated Escherichia coli pBR322 DNA cleavage assessed as ratio of drug-induced DNA cleavage to spontaneous DNA cleavage at 50 uM after 10 mins by gel electrophoresis,B,BAO_0000193,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154411,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,780045,=,1,0,=,Ratio,,24.7,CHEMBL612545,,Unchecked,,,Ratio,,,24.7
11390,,2496158,CHEMBL983314,Induction of Escherichia coli DNA topoisomerase 4-mediated negatively supercoiled Escherichia coli pBR322 DNA cleavage assessed as amount of linear DNA generated per unit amount of enzyme at 50 uM after 10 mins by gel electrophoresis,B,BAO_0000181,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154411,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,780045,=,1,0,=,Activity,ng,0.49,CHEMBL1895,Escherichia coli K-12,Topoisomerase IV subunit A,83333.0,,Activity,ng,UO_0000024,0.49
11391,,2496159,CHEMBL983315,Induction of Escherichia coli DNA topoisomerase 4 ParC E48K mutant-mediated negatively supercoiled Escherichia coli pBR322 DNA cleavage assessed as amount of linear DNA generated per unit amount of enzyme at 50 uM after 10 mins by gel electrophoresis,B,BAO_0000181,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154411,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,780045,=,1,0,=,Activity,ng,0.17,CHEMBL612545,,Unchecked,,,Activity,ng,UO_0000024,0.17
11392,,2496160,CHEMBL983316,Induction of Staphylococcus aureus DNA topoisomerase 4 ParC S80L mutant-mediated Escherichia coli pBR322 DNA cleavage assessed as ratio of drug-induced DNA cleavage to spontaneous DNA cleavage at 50 uM after 10 mins by gel electrophoresis,B,BAO_0000193,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154411,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,780045,=,1,0,=,Ratio,,1.96,CHEMBL1895,Escherichia coli K-12,Topoisomerase IV subunit A,83333.0,,Ratio,,,1.96
11393,,2496161,CHEMBL983317,Induction of Staphylococcus aureus DNA topoisomerase 4 ParC E48K mutant-mediated Escherichia coli pBR322 DNA cleavage assessed as ratio of drug-induced DNA cleavage to spontaneous DNA cleavage at 50 uM after 10 mins by gel electrophoresis,B,BAO_0000193,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154411,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,780045,=,1,0,=,Ratio,,1.21,CHEMBL612545,,Unchecked,,,Ratio,,,1.21
11394,,2496162,CHEMBL983318,Sensitivity ratio for induction of Escherichia coli DNA topoisomerase 4 over DNA gyrase-mediated negatively supercoiled Escherichia coli pBR322 DNA cleavage,B,BAO_0000193,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154411,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,780045,=,1,0,=,Ratio,,18.0,CHEMBL612545,,Unchecked,,,Ratio,,,18.0
11395,,2496163,CHEMBL983319,Sensitivity ratio for induction of Staphylococcus aureus DNA topoisomerase 4 over DNA gyrase-mediated negatively supercoiled Escherichia coli pBR322 DNA cleavage,B,BAO_0000193,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154411,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,780045,=,1,0,=,Ratio,,2.5,CHEMBL612545,,Unchecked,,,Ratio,,,2.5
11396,,2499750,CHEMBL992264,Antimicrobial activity against multidrug-resistant Escherichia coli C316 pHPA containing mutated GyrA gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,778897,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,128.0
11397,,2499772,CHEMBL992265,Antimicrobial activity against Escherichia coli KAM32 expressing deltaacrB ydhE hsd gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,778897,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
11398,,2499794,CHEMBL992266,Antimicrobial activity against Escherichia coli KAM32 pHPA containing mutated GyrA gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,778897,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
11399,,2499816,CHEMBL992267,Antimicrobial activity against Escherichia coli KAM32 pSTV28 containing chloramphenicol-resistant vector by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,778897,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
11400,,2499838,CHEMBL992268,Antimicrobial activity against Escherichia coli KAM32 pSTVqepA containing qepA gene ligated to pSTV28 plasmid by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,778897,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
11401,,2499860,CHEMBL992269,Antimicrobial activity against Escherichia coli KAM32 pSTVdeltaqepA containing disrupted qepA gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,778897,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
11402,,2499882,CHEMBL992270,Ratio of MIC for Escherichia coli KAM32 pSTVqepA mutant to MIC for Escherichia coli KAM32 pSTV28 mutant,F,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1143404,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,778897,=,1,0,=,Ratio,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,64.0
11403,,2500083,CHEMBL1016072,Antimicrobial activity against Mycoplasma putrefaciens French isolates after 24 hrs by twofold serial dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154426,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779507,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL613225,Mycoplasma putrefaciens,Mycoplasma putrefaciens,2123.0,,MIC50,ug ml-1,UO_0000274,2.0
11404,,2500084,CHEMBL1016073,Antimicrobial activity against Mycoplasma putrefaciens Jordanian isolates after 24 hrs by twofold serial dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154426,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779507,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL613225,Mycoplasma putrefaciens,Mycoplasma putrefaciens,2123.0,,MIC50,ug ml-1,UO_0000274,2.0
11405,,2500086,CHEMBL1016074,Antimicrobial activity against Mycoplasma putrefaciens KS1 after 24 hrs by twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154426,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779507,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL613225,Mycoplasma putrefaciens,Mycoplasma putrefaciens,2123.0,,MIC,ug ml-1,UO_0000274,2.0
11406,,2500089,CHEMBL1016073,Antimicrobial activity against Mycoplasma putrefaciens Jordanian isolates after 24 hrs by twofold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154426,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779507,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL613225,Mycoplasma putrefaciens,Mycoplasma putrefaciens,2123.0,,MIC90,ug ml-1,UO_0000274,2.0
11407,,2500094,CHEMBL1016072,Antimicrobial activity against Mycoplasma putrefaciens French isolates after 24 hrs by twofold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154426,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779507,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL613225,Mycoplasma putrefaciens,Mycoplasma putrefaciens,2123.0,,MIC90,ug ml-1,UO_0000274,4.0
11408,,2500243,CHEMBL1019527,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pAP2 plasmid containing Enterobacter cloacae acrA gene by standard disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,780150,=,1,1,=,IZ,mm,24.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,IZ,mm,UO_0000016,24.0
11409,,2500246,CHEMBL1019523,Antibacterial activity against drug-resistant Enterobacter cloacae EcDC64 isolate expressing AcrAB-TolC efflux pump by standard disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,780150,=,1,1,=,IZ,mm,26.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,IZ,mm,UO_0000016,26.0
11410,,2500248,CHEMBL1019530,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pBGS18 plasmid by standard disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,780150,=,1,1,=,IZ,mm,27.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,IZ,mm,UO_0000016,27.0
11411,,2500259,CHEMBL1019529,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pAP3 plasmid containing Enterobacter aerogenes acrR gene by standard disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,780150,=,1,1,=,IZ,mm,35.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,IZ,mm,UO_0000016,35.0
11412,,2500260,CHEMBL1019528,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pACYC184 plasmid by standard disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,780150,=,1,1,=,IZ,mm,38.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,IZ,mm,UO_0000016,38.0
11413,,2500262,CHEMBL1019524,Antibacterial activity against drug-resistant Enterobacter cloacae EcDC64 isolate expressing AcrAB-TolC efflux pump in presence of 20 ug/ml efflux pump inhibitor Phe-Arg-beta-naphthylamide by standard disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,780150,=,1,1,=,IZ,mm,40.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,IZ,mm,UO_0000016,40.0
11414,,2500263,CHEMBL1019525,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate by standard disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,780150,=,1,1,=,IZ,mm,40.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,IZ,mm,UO_0000016,40.0
11415,,2500264,CHEMBL1019526,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate in presence of 20 ug/ml efflux pump inhibitor Phe-Arg-beta-naphthylamide by standard disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,780150,=,1,1,=,IZ,mm,42.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,IZ,mm,UO_0000016,42.0
11416,,2500728,CHEMBL989558,Antimicrobial activity against methicillin-resistant Staphylococcus aureus effluxing isolate,F,BAO_0003035,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1143409,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779479,=,1,1,=,MIC50,ug.mL-1,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,12.5
11417,,2500729,CHEMBL989558,Antimicrobial activity against methicillin-resistant Staphylococcus aureus effluxing isolate,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1143409,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779479,>,1,1,>,MIC90,ug.mL-1,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,100.0
11418,,2500739,CHEMBL989562,Inhibition of multidrug-resistant efflux pump in methicillin-resistant Staphylococcus aureus effluxing isolate assessed as fold reduction of Norfloxacin MIC at 10 ug/ml by microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1143409,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,779479,=,1,0,=,FC,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,FC,,,4.0
11419,,2551547,CHEMBL978705,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 25923 after 18 hrs by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1157252,J Nat Prod,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,736026,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
11420,,2551549,CHEMBL978706,Antibacterial activity against multidrug-resistant Staphylococcus aureus SA-1199B overexpressing NorA efflux transporter after 18 hrs by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1157252,J Nat Prod,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,736026,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
11421,,2551551,CHEMBL978707,Antibacterial activity against Staphylococcus aureus RN4220 expressing MsrA efflux transporter after 18 hrs by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1157252,J Nat Prod,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,736026,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
11422,,2551553,CHEMBL978708,Antibacterial activity against methicillin-resistant Staphylococcus aureus XU212 expressing TetK efflux pump and MecA after 18 hrs by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1157252,J Nat Prod,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,736026,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
11423,,2551555,CHEMBL978709,Antibacterial activity against epidemic methicillin-resistant Staphylococcus aureus 15 expressing MecA after 18 hrs by microtiter plate method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1157252,J Nat Prod,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,736026,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
11424,,2555468,CHEMBL966719,Antimicrobial activity against Staphylococcus aureus ATCC 25923 by standard microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1157295,J Nat Prod,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,759811,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
11425,,2555491,CHEMBL966720,Antimicrobial activity against TetK multidrug efflux pump possessing Staphylococcus aureus XU-212 by standard microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1157295,J Nat Prod,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,759811,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
11426,,2555514,CHEMBL966721,Antimicrobial activity against NorA multidrug efflux pump overexpressing Staphylococcus aureus 1199B by ethidium efflux assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1157295,J Nat Prod,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,759811,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
11427,,2555537,CHEMBL966722,Antimicrobial activity against epidemic methicillin-resistant Staphylococcus aureus 15 by standard microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1157295,J Nat Prod,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,759811,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
11428,,2557080,CHEMBL982073,Antibacterial activity against Staphylococcus aureus 1199B overexpressing NorA efflux pump after 18 hrs by MTT assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155804,J Nat Prod,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,771602,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
11429,,2557081,CHEMBL982074,Antibacterial activity against Staphylococcus aureus RN42209 expressing MsrA macrolide efflux pump after 18 hrs by MTT assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155804,J Nat Prod,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,771602,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
11430,,2557082,CHEMBL982075,Antibacterial activity against epidemic methicillin-resistant Staphylococcus aureus 15 after 18 hrs by MTT assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155804,J Nat Prod,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,771602,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
11431,,2557083,CHEMBL982076,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 hrs by MTT assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155804,J Nat Prod,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,771602,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
11432,,2557084,CHEMBL982077,Antibacterial activity against methicillin-resistant Staphylococcus aureus XU212 expressing TetK efflux pump after 18 hrs by MTT assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155804,J Nat Prod,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,771602,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
11433,,2557085,CHEMBL982078,Antibacterial activity against epidemic methicillin-resistant Staphylococcus aureus 16 expressing mecA after 18 hrs by MTT assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155804,J Nat Prod,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,771602,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
11434,,2614042,CHEMBL1011609,Antitrypanosomal activity against wild type Trypanosoma brucei brucei s427 after 48 hrs by alamar blue assay,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1152793,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,805380,=,1,1,=,IC50,nM,39900.0,CHEMBL612851,Trypanosoma brucei brucei,Trypanosoma brucei brucei,5702.0,,IC50,uM,UO_0000065,39.9
11435,Active,2614712,CHEMBL1014291,Inhibition of DNA replication in wild type Trypanosoma brucei brucei s427 assessed as kinetoplast disintegrate at IC50 after 24 hrs by DAPI staining visualized by fluorescence microscopy,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1152793,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,805380,,1,0,,Activity,,,CHEMBL612851,Trypanosoma brucei brucei,Trypanosoma brucei brucei,5702.0,,Activity,,,
11436,Active,2626646,CHEMBL1006618,Antimicrobial activity against Escherichia coli isolate AMG1 24 hrs biofilms at 0.03 ug/ml to 0.12 ug/ml after 24 hrs by microtiter plate count method,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1137020,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,791999,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
11437,,2643799,CHEMBL1031922,Antimicrobial activity against Staphylococcus aureus after 24 hrs by tube dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1158343,Eur J Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,815301,=,1,0,=,MIC,10'-3micromol/ml,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,10'-3micromol/ml,,2.0
11438,,2643800,CHEMBL1031922,Antimicrobial activity against Staphylococcus aureus after 24 hrs by tube dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1158343,Eur J Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,815301,=,1,0,=,MBC,10'-3micromol/ml,19.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,10'-3micromol/ml,,19.0
11439,,2643801,CHEMBL1031923,Antimicrobial activity against Bacillus subtilis after 24 hrs by tube dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1158343,Eur J Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,815301,=,1,0,=,MIC,10'-3micromol/ml,2.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,10'-3micromol/ml,,2.0
11440,,2643802,CHEMBL1031923,Antimicrobial activity against Bacillus subtilis after 24 hrs by tube dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1158343,Eur J Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,815301,=,1,0,=,MBC,10'-3micromol/ml,19.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MBC,10'-3micromol/ml,,19.0
11441,,2643803,CHEMBL1031924,Antimicrobial activity against Escherichia coli after 24 hrs by tube dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1158343,Eur J Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,815301,=,1,0,=,MIC,10'-3micromol/ml,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,10'-3micromol/ml,,2.0
11442,,2643804,CHEMBL1031924,Antimicrobial activity against Escherichia coli after 24 hrs by tube dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1158343,Eur J Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,815301,=,1,0,=,MBC,10'-3micromol/ml,19.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,10'-3micromol/ml,,19.0
11443,,2657652,CHEMBL1033838,Antibacterial activity against Staphylococcus aureus after 24 hrs by tube dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1158369,Eur J Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,815077,=,1,0,=,-logMIC,,2.61,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,-logMIC,,,2.61
11444,,2657653,CHEMBL1033839,Antibacterial activity against Bacillus subtilis after 24 hrs by tube dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1158369,Eur J Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,815077,=,1,0,=,-logMIC,,2.61,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,-logMIC,,,2.61
11445,,2657654,CHEMBL1033840,Antibacterial activity against Escherichia coli after 24 hrs by tube dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1158369,Eur J Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,815077,=,1,0,=,-logMIC,,2.61,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,-logMIC,,,2.61
11446,,2660445,CHEMBL1061285,Antibacterial activity against wild type Pseudomonas aeruginosa PAO1 H103 after 24 hrs by broth microdilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817423,=,1,1,=,MIC,ug.mL-1,0.3,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.3
11447,,2660446,CHEMBL1061286,Antibacterial activity against 31_C9 allele containing Pseudomonas aeruginosa PAO1 H1104 mutant strain with lon::lux mutation after 24 hrs by broth microdilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817423,=,1,1,=,MIC,ug.mL-1,0.15,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.15
11448,,2660447,CHEMBL1061287,Antibacterial activity against 74_D9 allele containing Pseudomonas aeruginosa PAO1 H1105 mutant strain with lon::lux mutation after 24 hrs by broth microdilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817423,=,1,1,=,MIC,ug.mL-1,0.075,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.075
11449,,2660448,CHEMBL1061288,Antibacterial activity against 24_A2 allele containing Pseudomonas aeruginosa PAO1 H1106 mutant strain with lon::lux mutation after 24 hrs by broth microdilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817423,=,1,1,=,MIC,ug.mL-1,0.15,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.15
11450,,2660449,CHEMBL1061289,Antibacterial activity against 69_C12 allele containing Pseudomonas aeruginosa PAO1 H1109 mutant strain with recA::lux mutation after 24 hrs by broth microdilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817423,=,1,1,=,MIC,ug.mL-1,0.075,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.075
11451,,2660450,CHEMBL1061290,Antibacterial activity against 6_G1 allele containing Pseudomonas aeruginosa PAO1 H1121 mutant strain with PA4961::lux mutation after 24 hrs by broth microdilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817423,=,1,1,=,MIC,ug.mL-1,0.075,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.075
11452,,2660451,CHEMBL1061291,Antibacterial activity against 53_F11 allele containing Pseudomonas aeruginosa PAO1 H1124 mutant strain with PA5279::lux mutation after 24 hrs by broth microdilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817423,=,1,1,=,MIC,ug.mL-1,0.15,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.15
11453,,2660452,CHEMBL1061292,Antibacterial activity against 16_G12 allele containing Pseudomonas aeruginosa PAO1 H1125 mutant strain with recG::lux mutation after 24 hrs by broth microdilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817423,=,1,1,=,MIC,ug.mL-1,0.15,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.15
11454,,2660453,CHEMBL1061293,Antibacterial activity against Pseudomonas aeruginosa PAO1 H1105/lon+c mutant strain with lon::lux/lon+ mutation after 24 hrs by broth microdilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817423,=,1,1,=,MIC,ug.mL-1,0.3,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.3
11455,,2660454,CHEMBL1061294,Antibacterial activity against 70_H3 allele containing Pseudomonas aeruginosa PAO1 H1129 mutant strain with rnt::lux mutation after 24 hrs by broth microdilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817423,>,1,1,>,MIC,ug.mL-1,0.6,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.6
11456,,2660455,CHEMBL1061295,Antibacterial activity against 63_H5 allele containing Pseudomonas aeruginosa PAO1 H1133 mutant strain with nfxB::lux mutation after 24 hrs by broth microdilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817423,>,1,1,>,MIC,ug.mL-1,0.6,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.6
11457,,2660456,CHEMBL1061296,Antibacterial activity against 75_F11 allele containing Pseudomonas aeruginosa PAO1 H1136 mutant strain with PA5455::lux mutation after 24 hrs by broth microdilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817423,>,1,1,>,MIC,ug.mL-1,0.6,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.6
11458,,2660497,CHEMBL1061302,Antibacterial activity against 31_C9 allele containing Pseudomonas aeruginosa PAO1 H1104 mutant strain with lon::lux mutation assessed as fold decrease in MIC after 24 hrs by broth microdilution technique relative to wild type,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,817423,=,1,0,=,FC,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,4.0
11459,,2660498,CHEMBL1061303,Antibacterial activity against 74_D9 allele containing Pseudomonas aeruginosa PAO1 H1105 mutant strain with lon::lux mutation assessed as fold decrease in MIC after 24 hrs by broth microdilution technique relative to wild type,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,817423,=,1,0,=,FC,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,4.0
11460,,2660499,CHEMBL1061304,Antibacterial activity against 24_A2 allele containing Pseudomonas aeruginosa PAO1 H1106 mutant strain with lon::lux mutation assessed as fold decrease in MIC after 24 hrs by broth microdilution technique relative to wild type,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,817423,=,1,0,=,FC,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,4.0
11461,,2660500,CHEMBL1061305,Antibacterial activity against Pseudomonas aeruginosa PAO1 H1105/lon+ mutant strain with lon::lux mutation assessed as fold decrease in MIC after 24 hrs by broth microdilution technique relative to wild type,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151431,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,817423,=,1,0,=,FC,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FC,,,4.0
11462,,2662318,CHEMBL1023540,Antimicrobial activity against Escherichia coli J53-AzR in presence of IPTG,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818804,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
11463,,2662326,CHEMBL1023541,Antimicrobial activity against Escherichia coli DH10B expressing pCRQB10 in presence of IPTG,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818804,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
11464,,2662334,CHEMBL1023542,Antimicrobial activity against Escherichia coli DH10B expressing pCR2.1 in presence of IPTG,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818804,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
11465,,2662342,CHEMBL1023543,Antimicrobial activity against Escherichia coli DH10B in presence of IPTG,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818804,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
11466,Not Determined,2663375,CHEMBL1053039,Antibacterial activity against Mycobacterium fortuitum after 72 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151981,J Nat Prod,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,817781,,1,0,,MIC,,,CHEMBL614983,Mycolicibacterium fortuitum,Mycolicibacterium fortuitum,1766.0,,MIC,,,
11467,Not Determined,2663376,CHEMBL1053040,Antibacterial activity against Mycobacterium smegmatis after 72 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151981,J Nat Prod,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,817781,,1,0,,MIC,,,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,MIC,,,
11468,Not Determined,2663377,CHEMBL1053041,Antibacterial activity against Mycobacterium smegmatis mc2 2700 after 72 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151981,J Nat Prod,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,817781,,1,0,,MIC,,,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,MIC,,,
11469,Not Determined,2663378,CHEMBL1053042,Antibacterial activity against Mycobacterium phlei after 72 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151981,J Nat Prod,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,817781,,1,0,,MIC,,,CHEMBL614985,Mycolicibacterium phlei,Mycolicibacterium phlei,1771.0,,MIC,,,
11470,,2663379,CHEMBL1053043,Antibacterial activity against Staphylococcus aureus SA1199B overexpressing NorA efflux pump after 72 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151981,J Nat Prod,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817781,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
11471,,2663380,CHEMBL1053044,Antibacterial activity against tetracycline-effluxing Staphylococcus aureus XU212 after 72 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151981,J Nat Prod,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817781,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
11472,,2663381,CHEMBL1053045,Antibacterial activity against Staphylococcus aureus EMRSA15 after 72 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151981,J Nat Prod,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,817781,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
11473,,2663964,CHEMBL1023510,Antimicrobial activity against multidrug-resistant Enterobacter cloacae E705 bearing qnrB10 gene with aac(6)-IId-aadA1a integron in presence of IPTG,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818804,>=,1,1,>=,MIC,ug.mL-1,64.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,64.0
11474,,2663972,CHEMBL1023538,Antimicrobial activity against multidrug-resistant Klebsiella pneumoniae M7943 bearing qnrB10 gene with aac(6)-Ib-cr-blaOXA-30 catB3-arr-3 integron in presence of IPTG,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818804,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,32.0
11475,,2663980,CHEMBL1023539,Antimicrobial activity against multidrug-resistant Escherichia coli M7943-TC2 bearing qnrB10 gene with aac(6)-Ib-cr-blaOXA-30 catB3-arr-3 integron in presence of IPTG,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1151447,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818804,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
11476,,2704211,CHEMBL1059791,Antibacterial activity against Staphylococcus aureus 1199B overexpressing NorA after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1153024,J Nat Prod,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,827026,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
11477,,2704212,CHEMBL1059794,Antibacterial activity against Staphylococcus aureus EMRSA-15 after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1153024,J Nat Prod,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,827026,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
11478,,2704213,CHEMBL1059795,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1153024,J Nat Prod,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,827026,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
11479,,2711141,CHEMBL1053372,"Antibacterial activity against Escherichia coli 1596 containing gyrA L83 and parC I80, G84 mutants assessed as increase in MIC by Etest relative to MIC for Escherichia coli 1608 containing gyrA mutant",F,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1152985,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,826319,=,1,0,=,Ratio,,5.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,5.0
11480,,2711147,CHEMBL1053371,"Antibacterial activity against Escherichia coli 1608 containing gyrA L83, L87 mutants assessed as increase in MIC by Etest relative to MIC for wild type Escherichia coli 1609",F,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1152985,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,826319,=,1,0,=,Ratio,,5.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,5.0
11481,,2711159,CHEMBL1053374,"Antibacterial activity against Escherichia coli SKM9 containing gyrA L83, Y87 and parC L80 mutants assessed as increase in MIC by Etest relative to MIC for Escherichia coli 1596 containing gyrA L83 and parC I80 mutants",F,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1152985,Antimicrob Agents Chemother,2007.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,826319,=,1,0,=,Ratio,,9.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,9.0
11482,,2725278,CHEMBL1053490,Antibacterial activity against multidrug-resistant Escherichia coli after 20 hrs by cylinder and well method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1153606,Bioorg Med Chem Lett,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,829485,=,1,1,=,IZ,mm,20.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,20.0
11483,,2725279,CHEMBL1053491,Antibacterial activity against multidrug-resistant Escherichia coli broth after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1153606,Bioorg Med Chem Lett,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829485,=,1,1,=,MIC,ug.mL-1,1.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.3
11484,,2725280,CHEMBL1053489,Antibacterial activity against multidrug-resistant Pseudomonas aeruginosa after 20 hrs by cylinder and well method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1153606,Bioorg Med Chem Lett,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,829485,=,1,1,=,IZ,mm,28.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,IZ,mm,UO_0000016,28.0
11485,,2725281,CHEMBL1053488,Antibacterial activity against multidrug-resistant Pseudomonas aeruginosa after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1153606,Bioorg Med Chem Lett,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829485,=,1,1,=,MIC,ug.mL-1,1.8,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.8
11486,,2725282,CHEMBL1053486,Antibacterial activity against multidrug-resistant Streptococcus pneumoniae after 20 hrs by cylinder and well method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1153606,Bioorg Med Chem Lett,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,829485,=,1,1,=,IZ,mm,22.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,IZ,mm,UO_0000016,22.0
11487,,2725283,CHEMBL1053487,Antibacterial activity against multidrug-resistant Streptococcus pneumoniae after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1153606,Bioorg Med Chem Lett,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829485,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.12
11488,,2725284,CHEMBL1053485,Antibacterial activity against multidrug-resistant Streptococcus agalactiae after 20 hrs by cylinder and well method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1153606,Bioorg Med Chem Lett,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,829485,=,1,1,=,IZ,mm,32.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,IZ,mm,UO_0000016,32.0
11489,,2725285,CHEMBL1053484,Antibacterial activity against multidrug-resistant Streptococcus agalactiae after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1153606,Bioorg Med Chem Lett,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829485,=,1,1,=,MIC,ug.mL-1,22.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,22.0
11490,,2725286,CHEMBL1052762,Antibacterial activity against multidrug-resistant Salmonella typhi after 20 hrs by cylinder and well method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1153606,Bioorg Med Chem Lett,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,829485,=,1,1,=,IZ,mm,24.0,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,IZ,mm,UO_0000016,24.0
11491,,2725287,CHEMBL1052761,Antibacterial activity against multidrug-resistant Salmonella typhi after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1153606,Bioorg Med Chem Lett,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829485,=,1,1,=,MIC,ug.mL-1,20.2,CHEMBL613044,Salmonella enterica subsp. enterica,Salmonella enterica subsp. enterica,59201.0,,MIC,ug ml-1,UO_0000274,20.2
11492,,2725288,CHEMBL1052760,Antibacterial activity against multidrug-resistant Staphylococcus aureus after 20 hrs by cylinder and well method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1153606,Bioorg Med Chem Lett,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,829485,=,1,1,=,IZ,mm,28.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,28.0
11493,,2725289,CHEMBL1052759,Antibacterial activity against multidrug-resistant Staphylococcus aureus after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1153606,Bioorg Med Chem Lett,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829485,=,1,1,=,MIC,ug.mL-1,1.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.5
11494,,2725290,CHEMBL1052757,Antibacterial activity against multidrug-resistant Streptococcus pyogenes after 20 hrs by cylinder and well method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1153606,Bioorg Med Chem Lett,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,829485,=,1,1,=,IZ,mm,30.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,IZ,mm,UO_0000016,30.0
11495,,2725291,CHEMBL1052758,Antibacterial activity against multidrug-resistant Streptococcus pyogenes after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1153606,Bioorg Med Chem Lett,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,829485,=,1,1,=,MIC,ug.mL-1,2.6,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,2.6
11496,,2914865,CHEMBL1050066,Inhibition of mouse NIH/3T3 cell proliferation by MTT assay,A,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1154114,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,847494,>,1,1,>,IC50,nM,1000000.0,CHEMBL612558,,ADMET,,,IC50,uM,UO_0000065,1000.0
11497,,2924433,CHEMBL1043233,Antibacterial activity against Escherichia coli ATCC 8739 by turbidity method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155199,Eur J Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,849945,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,6.25
11498,,2924451,CHEMBL1043235,Antibacterial activity against Staphylococcus aureus ATCC 29737 by turbidity method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155199,Eur J Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,849945,=,1,1,=,MIC,ug.mL-1,6.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,6.25
11499,,2998753,CHEMBL1045436,Antimicrobial activity against Staphylococcus aureus ATCC 11632 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155277,Eur J Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,857010,<=,1,1,<=,MIC,ug.mL-1,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,5.0
11500,,2998779,CHEMBL1045437,Antimicrobial activity against Streptococcus faecalis ATCC 14506 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155277,Eur J Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,857010,<=,1,1,<=,MIC,ug.mL-1,5.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,5.0
11501,,2998804,CHEMBL1045438,Antimicrobial activity against Bacillus subtilis ATCC 60511 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155277,Eur J Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,857010,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,1.0
11502,,2998829,CHEMBL1045439,Antimicrobial activity against Klebsiella pneumoniae ATCC 10031 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155277,Eur J Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,857010,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
11503,,2998854,CHEMBL1045440,Antimicrobial activity against Escherichia coli ATCC 10145 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155277,Eur J Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,857010,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
11504,,2998879,CHEMBL1045441,Antimicrobial activity against Pseudomonas aeruginosa ATCC 10145 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155277,Eur J Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,857010,<=,1,1,<=,MIC,ug.mL-1,5.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,5.0
11505,,2999123,CHEMBL1038343,Antifungal activity against Rhizoctonia solani at 200 mg/L by plate growth rate method,F,BAO_0000096,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155265,Eur J Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,854840,=,1,0,=,GI,%,0.0,CHEMBL613272,Rhizoctonia solani,Rhizoctonia solani,456999.0,,GI,%,UO_0000187,0.0
11506,,2999153,CHEMBL1038342,Antibacterial activity against Ralstonia solanacearum at 50 mg/L after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155265,Eur J Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,854840,=,1,1,=,IZ,mm,19.31,CHEMBL612602,Ralstonia solanacearum,Ralstonia solanacearum,305.0,,DIZ,mm,UO_0000016,19.31
11507,,2999183,CHEMBL1038341,Antibacterial activity against Bacillus subtilis at 50 mg/L after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155265,Eur J Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,854840,=,1,1,=,IZ,mm,30.49,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,DIZ,mm,UO_0000016,30.49
11508,,2999213,CHEMBL1038340,Antibacterial activity against Erwinia aroideae at 50 mg/L after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155265,Eur J Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,854840,=,1,1,=,IZ,mm,21.52,CHEMBL615081,Erwinia,Erwinia,551.0,,DIZ,mm,UO_0000016,21.52
11509,,2999243,CHEMBL1038339,Antibacterial activity against Xanthomonas axonopodis at 50 mg/L after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155265,Eur J Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,854840,=,1,1,=,IZ,mm,17.74,CHEMBL615102,Xanthomonas axonopodis,Xanthomonas axonopodis,53413.0,,DIZ,mm,UO_0000016,17.74
11510,,2999273,CHEMBL1038338,Antibacterial activity against Xanthomonas oryzae at 50 mg/L after 24 hrs by agar well diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155265,Eur J Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,854840,=,1,1,=,IZ,mm,22.19,CHEMBL613861,Xanthomonas oryzae,Xanthomonas oryzae,347.0,,DIZ,mm,UO_0000016,22.19
11511,,2999321,CHEMBL1038344,Antifungal activity against Gibberella zeae at 200 mg/L by plate growth rate method,F,BAO_0000096,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155265,Eur J Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,854840,=,1,0,=,GI,%,18.0,CHEMBL2366834,Fusarium graminearum,Fusarium graminearum,5518.0,,GI,%,UO_0000187,18.0
11512,,2999351,CHEMBL1038345,Antifungal activity against Valsa mali at 200 mg/L by plate growth rate method,F,BAO_0000096,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155265,Eur J Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,854840,=,1,0,=,GI,%,27.0,CHEMBL613169,Valsa mali,Valsa mali,105487.0,,GI,%,UO_0000187,27.0
11513,,3071176,CHEMBL1044210,Antibacterial activity against Staphylococcus aureus after 24 hrs by twofold serial dilution method,F,BAO_0000181,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1152508,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Micromolar,874695,=,1,0,=,Activity,uM,2.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,uM,UO_0000064,2.5
11514,,3071177,CHEMBL1044211,Antibacterial activity against Bacillus subtilis after 24 hrs by twofold serial dilution method,F,BAO_0000181,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1152508,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Micromolar,874695,=,1,0,=,Activity,uM,2.51,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,Activity,uM,UO_0000064,2.51
11515,,3071178,CHEMBL1044212,Antibacterial activity against Serratia marcescens after 24 hrs by twofold serial dilution method,F,BAO_0000181,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1152508,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Micromolar,874695,=,1,0,=,Activity,uM,4.07,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,Activity,uM,UO_0000064,4.07
11516,,3071179,CHEMBL1044213,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by twofold serial dilution method,F,BAO_0000181,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1152508,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Micromolar,874695,=,1,0,=,Activity,uM,3.76,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,uM,UO_0000064,3.76
11517,,3071180,CHEMBL1044214,Antibacterial activity against Escherichia coli after 24 hrs by twofold serial dilution method,F,BAO_0000181,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1152508,Bioorg Med Chem,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Micromolar,874695,=,1,0,=,Activity,uM,2.82,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,uM,UO_0000064,2.82
11518,,3188178,CHEMBL1106913,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by two fold serial dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155420,Bioorg Med Chem Lett,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,896394,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,8.0
11519,,3188193,CHEMBL1107765,Antibacterial activity against Methicillin-Resistant Staphylococcus aureus subsp. aureus N315 after 24 hrs by two fold serial dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155420,Bioorg Med Chem Lett,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,896394,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,1.0
11520,,3188208,CHEMBL1107766,Antibacterial activity against Bacillus subtilis ATCC 21216 after 24 hrs by two fold serial dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155420,Bioorg Med Chem Lett,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,896394,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC50,ug ml-1,UO_0000274,1.0
11521,,3188223,CHEMBL1107767,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by two fold serial dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155420,Bioorg Med Chem Lett,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,896394,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,0.5
11522,,3188238,CHEMBL1107768,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by two fold serial dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155420,Bioorg Med Chem Lett,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,896394,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC50,ug ml-1,UO_0000274,2.0
11523,,3188253,CHEMBL1107769,Antibacterial activity against Proteus vulgaris ATCC 49027 after 24 hrs by two fold serial dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1155420,Bioorg Med Chem Lett,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,896394,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC50,ug ml-1,UO_0000274,1.0
11524,,3276436,CHEMBL1105747,Antimicrobial activity against Pseudomonas aeruginosa ATCC 10145 after 24 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1157864,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,911810,=,1,1,=,MIC,ug.mL-1,5.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,5.0
11525,,3276437,CHEMBL1105746,Antimicrobial activity against Escherichia coli ATCC 10536 after 24 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1157864,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,911810,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
11526,,3276438,CHEMBL1105745,Antimicrobial activity against Klebsiella pneumoniae ATCC 10031 after 24 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1157864,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,911810,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
11527,,3276439,CHEMBL1105744,Antimicrobial activity against Bacillus subtilis ATCC 60511 after 24 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1157864,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,911810,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,1.0
11528,,3276440,CHEMBL1104909,Antimicrobial activity against Streptococcus faecalis ATCC 14506 after 24 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1157864,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,911810,=,1,1,=,MIC,ug.mL-1,5.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,5.0
11529,,3276441,CHEMBL1104908,Antimicrobial activity against Staphylococcus aureus ATCC 11632 after 24 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1157864,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,911810,=,1,1,=,MIC,ug.mL-1,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,5.0
11530,,3346990,CHEMBL1174290,Antibacterial activity against Bacillus subtilis at 50 ug after 48 hrs by agar well diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1177879,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,923155,=,1,1,=,IZ,mm,28.3,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,IZ,mm,UO_0000016,28.3
11531,,3346991,CHEMBL1174291,Antibacterial activity against Escherichia coli at 50 ug after 48 hrs by agar well diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1177879,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,923155,=,1,1,=,IZ,mm,28.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,28.3
11532,,3371293,CHEMBL1211318,Antibacterial activity against Bacillus subtilis ATCC 6633 at 100 ug after 24 hrs by paper disc method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1208678,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,928069,=,1,1,=,IZ,mm,35.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,IZ,mm,UO_0000016,35.0
11533,,3371297,CHEMBL1211320,Antibacterial activity against Staphylococcus aureus ATCC 6538 at 100 ug after 24 hrs by paper disc method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1208678,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,928069,=,1,1,=,IZ,mm,27.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,IZ,mm,UO_0000016,27.0
11534,,3371298,CHEMBL1211322,Antibacterial activity against Escherichia coli ATCC 7839 at 100 ug after 24 hrs by paper disc method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1208678,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,928069,=,1,1,=,IZ,mm,17.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,IZ,mm,UO_0000016,17.0
11535,,3371299,CHEMBL1211324,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 at 100 ug after 24 hrs by paper disc method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1208678,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,928069,=,1,1,=,IZ,mm,15.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,IZ,mm,UO_0000016,15.0
11536,Active,3383876,CHEMBL1220796,Antimicrobial activity against strong ciprofloxacin-resistant Streptococcus pyogenes assessed as 1 fold decrease in compound MIC by agar dilution method,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,930561,,1,0,,Activity,,,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,Activity,,,
11537,Active,3383877,CHEMBL1220797,Antimicrobial activity against mild ciprofloxacin-resistant Streptococcus pyogenes assessed as 1 fold decrease in compound MIC by agar dilution method,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,930561,,1,0,,Activity,,,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,Activity,,,
11538,Active,3383878,CHEMBL1220802,Antimicrobial activity against ciprofloxacin-susceptible Streptococcus pyogenes harboring Asp91/Asn mutation in parC gene assessed as 1 fold decrease in compound MIC by agar dilution method,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,930561,,1,0,,Activity,,,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,Activity,,,
11539,,3383882,CHEMBL1220798,Antimicrobial activity against mild ciprofloxacin-resistant Streptococcus pyogenes at 10 ug by disk diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,930561,=,1,1,=,IZ,mm,0.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,IZ,mm,UO_0000016,0.0
11540,,3383883,CHEMBL1220799,Antimicrobial activity against strong ciprofloxacin-resistant Streptococcus pyogenes at 10 ug by disk diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,930561,=,1,1,=,IZ,mm,0.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,IZ,mm,UO_0000016,0.0
11541,,3383884,CHEMBL1220800,Antimicrobial activity against ciprofloxacin-susceptible Streptococcus pyogenes harboring Asp91/Asn mutation in parC gene at 10 ug by disk diffusion assay,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,930561,=,1,1,=,IZ,mm,0.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,IZ,mm,UO_0000016,0.0
11542,,3384909,CHEMBL1220654,Apparent permeability across apical to basolateral side in human Calu3 cells,A,BAO_0002808,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212744,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,929466,=,1,0,=,Papp,10'-6 cm/s,0.6,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,0.6
11543,,3384915,CHEMBL1220655,Apparent permeability across basolateral to apical side in human Calu3 cells,A,BAO_0002808,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212744,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,929466,=,1,0,=,Papp,10'-6 cm/s,2.0,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,2.0
11544,,3384921,CHEMBL1220656,Efflux ratio of apparent permeability across basolateral to apical side over apical to basolateral side in human Calu3 cells,A,BAO_0000193,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212744,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,929466,=,1,0,=,Ratio,,3.3,CHEMBL612558,,ADMET,,,Ratio,,,3.3
11545,,3384927,CHEMBL1220657,Apparent permeability across apical to basolateral side in human Calu3 cells in presence of 3 uM PSC-833 P-gp inhibitor,A,BAO_0002808,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212744,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,929466,=,1,0,=,Papp,10'-6 cm/s,0.7,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,0.7
11546,,3384933,CHEMBL1220658,Apparent permeability across basolateral to apical side in human Calu3 cells in presence of 3 uM PSC-833 P-gp inhibitor,A,BAO_0002808,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212744,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,929466,=,1,0,=,Papp,10'-6 cm/s,0.6,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,0.6
11547,,3384939,CHEMBL1220659,Efflux ratio of apparent permeability across basolateral to apical side over apical to basolateral side in human Calu3 cells in presence of 3 uM PSC-833 P-gp inhibitor,A,BAO_0000193,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212744,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,929466,=,1,0,=,Ratio,,0.8,CHEMBL612558,,ADMET,,,Ratio,,,0.8
11548,,3386469,CHEMBL1218425,Antibacterial activity against Acinetobacter baumannii BM4454 by antimicrobial susceptibility assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212768,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930151,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,256.0
11549,,3386470,CHEMBL1218424,Antibacterial activity against Acinetobacter baumannii BM4587 by antimicrobial susceptibility assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212768,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930151,=,1,1,=,MIC,ug.mL-1,1.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,1.5
11550,,3386471,CHEMBL1218426,Antibacterial activity against multidrug-resistant Acinetobacter baumannii BM4665 by antimicrobial susceptibility assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212768,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930151,=,1,1,=,MIC,ug.mL-1,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,12.0
11551,,3386472,CHEMBL1218427,Antibacterial activity against multidrug-resistant Acinetobacter baumannii BM4666 by antimicrobial susceptibility assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212768,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930151,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,4.0
11552,,3386473,CHEMBL1218428,Antibacterial activity against Acinetobacter baumannii BM4467 by antimicrobial susceptibility assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212768,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930151,=,1,1,=,MIC,ug.mL-1,1.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,1.5
11553,,3386474,CHEMBL1218429,Antibacterial activity against multidrug-resistant Acinetobacter baumannii BM4668 by antimicrobial susceptibility assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212768,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930151,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,4.0
11554,,3386475,CHEMBL1218430,Antibacterial activity against Acinetobacter baumannii CIP70-10 by antimicrobial susceptibility assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212768,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930151,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,2.0
11555,,3386476,CHEMBL1218431,Antibacterial activity against multidrug-resistant Acinetobacter baumannii AYE by antimicrobial susceptibility assay,F,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212768,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930151,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,256.0
11556,,3386477,CHEMBL1218432,Antibacterial activity against multidrug-resistant Acinetobacter baumannii BM4675 by antimicrobial susceptibility assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212768,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930151,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,256.0
11557,,3386478,CHEMBL1218433,Antibacterial activity against multidrug-resistant Acinetobacter baumannii BM4676 by antimicrobial susceptibility assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212768,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930151,=,1,1,=,MIC,ug.mL-1,192.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,192.0
11558,,3390342,CHEMBL1217000,Antimicrobial activity against Plasmodium falciparum,F,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212812,Bioorg Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,929159,=,1,1,=,IC50,nM,75000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,IC50,uM,UO_0000065,75.0
11559,Not Active,3397338,CHEMBL1218540,Binding affinity to Escherichia coli K-12 MC1061 acrB assessed as susceptibility to compound efflux at 0.01 to 1 ug/ml after 16 hrs by plate reader assay,B,BAO_0000375,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212733,Nat Chem Biol,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,930451,,1,0,,Activity,,,CHEMBL1681614,Escherichia coli (strain K12),Acriflavine resistance protein B,83333.0,,Activity,,,
11560,,3397705,CHEMBL1220793,Antimicrobial activity against strong ciprofloxacin-resistant Streptococcus pyogenes by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930561,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,64.0
11561,,3397712,CHEMBL1220794,Antimicrobial activity against mild ciprofloxacin-resistant Streptococcus pyogenes by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930561,=,1,1,=,MIC50,ug.mL-1,32.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC50,ug ml-1,UO_0000274,32.0
11562,,3397719,CHEMBL1220794,Antimicrobial activity against mild ciprofloxacin-resistant Streptococcus pyogenes by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930561,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,ug ml-1,UO_0000274,32.0
11563,,3397726,CHEMBL1220795,Antimicrobial activity against ciprofloxacin-susceptible Streptococcus pyogenes harboring Asp91/Asn mutation in parC gene by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930561,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC50,ug ml-1,UO_0000274,4.0
11564,,3397733,CHEMBL1220795,Antimicrobial activity against ciprofloxacin-susceptible Streptococcus pyogenes harboring Asp91/Asn mutation in parC gene by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1212736,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,930561,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,ug ml-1,UO_0000274,8.0
11565,,3413553,CHEMBL1228893,Antimicrobial activity against Escherichia coli MTCC 443 by broth microdilution technique,F,BAO_0003035,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1221384,Bioorg Med Chem Lett,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,938477,=,1,1,=,MIC50,ug.mL-1,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC50,ug ml-1,UO_0000274,10.0
11566,,3413554,CHEMBL1228894,Antimicrobial activity against Pseudomonas aeruginosa MTCC 1688 by broth microdilution technique,F,BAO_0003035,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1221384,Bioorg Med Chem Lett,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,938477,=,1,1,=,MIC50,ug.mL-1,10.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC50,ug ml-1,UO_0000274,10.0
11567,,3413555,CHEMBL1228895,Antimicrobial activity against Staphylococcus aureus MTCC 96 by broth microdilution technique,F,BAO_0003035,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1221384,Bioorg Med Chem Lett,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,938477,=,1,1,=,MIC50,ug.mL-1,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,10.0
11568,,3413556,CHEMBL1228896,Antimicrobial activity against Bacillus subtilis MTCC 441 by broth microdilution technique,F,BAO_0003035,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1221384,Bioorg Med Chem Lett,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,938477,=,1,1,=,MIC50,ug.mL-1,100.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC50,ug ml-1,UO_0000274,100.0
11569,,3423467,CHEMBL1227573,Antimicrobial activity against methicillin-resistant Staphylococcus aureus OM481 after 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1221243,Bioorg Med Chem Lett,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,934518,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
11570,,3423468,CHEMBL1227574,Antimicrobial activity against methicillin-resistant Staphylococcus aureus OM584 after 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1221243,Bioorg Med Chem Lett,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,934518,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
11571,,3423469,CHEMBL1227575,Antimicrobial activity against methicillin-resistant Staphylococcus aureus N315 after 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1221243,Bioorg Med Chem Lett,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,934518,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
11572,,3423470,CHEMBL1227576,Antimicrobial activity against methicillin-resistant Staphylococcus aureus COL after 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1221243,Bioorg Med Chem Lett,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,934518,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
11573,,3423471,CHEMBL1227577,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus 209P after 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1221243,Bioorg Med Chem Lett,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,934518,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
11574,,3423472,CHEMBL1227578,Inhibition of Escherichia coli DNA gyraseB assessed as inhibition of pBR322 supercoiling by densitometry,B,BAO_0000190,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1221243,Bioorg Med Chem Lett,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,934518,=,1,1,=,IC50,nM,90.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,0.09
11575,,3423473,CHEMBL1227580,Antimicrobial activity against Escherichia coli K-12 after 24 hrs by microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1221243,Bioorg Med Chem Lett,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,934518,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
11576,,3423509,CHEMBL1227578,Inhibition of Escherichia coli DNA gyraseB assessed as inhibition of pBR322 supercoiling by densitometry,B,BAO_0000192,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1221243,Bioorg Med Chem Lett,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,934518,=,1,1,=,Ki,nM,0.09,CHEMBL612545,,Unchecked,,,Ki,10'-3microM,UO_0000065,0.09
11577,,3431979,CHEMBL1246426,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by micro-broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1240446,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,952613,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
11578,,3431980,CHEMBL1246425,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 after 24 hrs by micro-broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1240446,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,952613,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
11579,,3431985,CHEMBL1246427,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by micro-broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1240446,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,952613,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
11580,,3431989,CHEMBL1246424,Antibacterial activity against Bacillus subtilis ATCC 21216 after 24 hrs by micro-broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1240446,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,952613,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,1.0
11581,,3431990,CHEMBL1246431,Antibacterial activity against Bacillus proteus ATCC 13315 after 24 hrs by micro-broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1240446,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,952613,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL612428,Bacillus,Bacillus,1386.0,,MIC,ug ml-1,UO_0000274,1.0
11582,,3431999,CHEMBL1246428,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by micro-broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1240446,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,952613,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
11583,,3439797,CHEMBL1249442,Antimicrobial activity against Staphylococcus aureus,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1240316,Nat Chem Biol,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953036,=,1,1,=,MIC,ug.mL-1,0.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.7
11584,,3439798,CHEMBL1249443,Antimicrobial activity against Staphylococcus aureus expressing mgrA C12S mutant gene,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1240316,Nat Chem Biol,2006.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,953036,=,1,1,=,MIC,ug.mL-1,1.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.4
11585,,3453785,CHEMBL1246594,Antibacterial activity against tetracycline sulfamethoxazole streptomycin kanamycin-resistant Escherichia coli isolate M66-6 carrying qnrB19 gene,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1240376,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,952542,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
11586,,3453786,CHEMBL1246595,Antibacterial activity against ampicillin tetracycline trimethoprim sulfamethoxazole streptomycin-resistant Escherichia coli isolate Y6-7 carrying qnrB19 gene,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1240376,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,952542,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
11587,,3453787,CHEMBL1246596,Antibacterial activity against tetracycline trimethoprim sulfamethoxazole kanamycin-resistant Escherichia coli isolate C14-9 carrying qnrB19 gene,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1240376,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,952542,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
11588,,3453788,CHEMBL1246597,Antibacterial activity against ampicillin sulfamethoxazole streptomycin kanamycin-resistant Escherichia coli isolate V6-9 carrying qnrB19 gene,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1240376,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,952542,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
11589,,3453789,CHEMBL1246761,Antibacterial activity against ampicillin tetracyclin streptomycin kanamycin-resistant Escherichia coli isolate V32-1 carrying qnrB19 gene,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1240376,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,952542,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
11590,,3453790,CHEMBL1246762,Antibacterial activity against Escherichia coli HB101,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1240376,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,952542,=,1,1,=,MIC,ug.mL-1,0.003,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.003
11591,,3475053,CHEMBL1264027,Antimicrobial activity against Escherichia coli DH10B harboring p05283 carrying qepA and rmtB gene by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255325,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960382,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
11592,,3475054,CHEMBL1264026,Antimicrobial activity against Escherichia coli DH10B harboring p041060 carrying qepA gene by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255325,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960382,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
11593,,3475067,CHEMBL1264028,Antimicrobial activity against Escherichia coli isolate DH10B by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255325,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960382,<=,1,1,<=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
11594,,3475070,CHEMBL1263846,Antimicrobial activity against Escherichia coli MRY04-1060 expressing qepA gene by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255325,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960382,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,128.0
11595,,3475071,CHEMBL1263847,Antimicrobial activity against Escherichia coli MRY05-3283 expressing qepA and rmtB gene by agar dilution CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255325,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,960382,>,1,1,>,MIC,ug.mL-1,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,128.0
11596,,3475086,CHEMBL1264029,Ratio of MIC for Escherichia coli DH10B harboring p041060 carrying qepA gene to MIC for Escherichia coli isolate DH10B,F,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255325,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,960382,=,1,0,=,Ratio,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,4.0
11597,,3475087,CHEMBL1264030,Ratio of MIC for Escherichia coli DH10B harboring p05283 carrying qepA and rmtB gene to MIC for Escherichia coli isolate DH10B,F,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255325,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,960382,=,1,0,=,Ratio,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,4.0
11598,,3481615,CHEMBL1267919,"Antimicrobial activity against fluoroquinolone-resistant Escherichia coli NorE5 harboring GyrA S83L mutant, ParC S80R mutant, truncated SoxR and constitutively active SoxS by Etest",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255385,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959882,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
11599,,3481624,CHEMBL1267918,Antimicrobial activity against fluoroquinolone-susceptible Escherichia coli PS5 harboring GyrA S83L mutant gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255385,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,959882,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
11600,,3482727,CHEMBL1267279,Antibacterial activity against erythromycin resistant Campylobacter sp. by agar plate dilution method,F,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255394,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961924,>,1,1,>,MIC90,ug.mL-1,64.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,64.0
11601,,3482741,CHEMBL1267364,Antibacterial activity against erythromycin susceptible Campylobacter sp. assessed as resistance breakpoint by CLSI method,F,BAO_0001103,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255394,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,961924,=,1,0,=,Activity,%,39.6,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,39.6
11602,,3482751,CHEMBL1267281,Antibacterial activity against erythromycin resistant Campylobacter sp. assessed as resistance breakpoint by CLSI method,F,BAO_0001103,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255394,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,961924,=,1,0,=,Activity,%,94.7,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,94.7
11603,,3482768,CHEMBL1267280,Antibacterial activity against erythromycin susceptible Campylobacter sp. by agar plate dilution method,F,BAO_0003035,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255394,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961924,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,8.0
11604,,3482784,CHEMBL1267279,Antibacterial activity against erythromycin resistant Campylobacter sp. by agar plate dilution method,F,BAO_0003035,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255394,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961924,=,1,1,=,MIC50,ug.mL-1,64.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,64.0
11605,,3482802,CHEMBL1266698,Antibacterial activity against Campylobacter sp. assessed as resistance breakpoint by CLSI method,F,BAO_0000181,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255394,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961924,=,1,0,=,Activity,ug ml-1,16.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,ug ml-1,UO_0000274,16.0
11606,,3482809,CHEMBL1266696,Antibacterial activity against Campylobacter jejuni assessed as resistant isolates by disk diffusion method,F,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255394,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,961924,=,1,0,=,Activity,%,40.9,CHEMBL612492,Campylobacter jejuni,Campylobacter jejuni,197.0,,Activity,%,UO_0000187,40.9
11607,,3482824,CHEMBL1266697,Antibacterial activity against Campylobacter coli assessed as resistant isolates by disk diffusion method,F,BAO_0001103,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255394,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,961924,=,1,0,=,Activity,%,83.3,CHEMBL3301405,Campylobacter coli,Campylobacter coli,195.0,,Activity,%,UO_0000187,83.3
11608,,3482844,CHEMBL1267280,Antibacterial activity against erythromycin susceptible Campylobacter sp. by agar plate dilution method,F,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255394,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961924,=,1,1,=,MIC90,ug.mL-1,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,256.0
11609,,3483150,CHEMBL1265789,Antimicrobial activity against Escherichia coli ATCC 10536 after 18 hrs by rapid INT colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
11610,,3483151,CHEMBL1265790,Antimicrobial activity against Escherichia coli ATCC 10536 after 18 hrs by rapid INT colorimetric assay in presence of efflux pump inhibitor phenylalanine arginine beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
11611,,3483152,CHEMBL1265791,Antimicrobial activity against Escherichia coli ATCC 8739 after 18 hrs by rapid INT colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.12
11612,,3483153,CHEMBL1265792,Antimicrobial activity against Escherichia coli ATCC 8739 after 18 hrs by rapid INT colorimetric assay in presence of efflux pump inhibitor phenylalanine arginine,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.12
11613,,3483154,CHEMBL1265793,Antimicrobial activity against Escherichia coli AG100 after 18 hrs by rapid INT colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.12
11614,,3483155,CHEMBL1265794,Antimicrobial activity against Escherichia coli AG100 after 18 hrs by rapid INT colorimetric assay in presence of efflux pump inhibitor phenylalanine arginine,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.12
11615,,3483156,CHEMBL1265795,Antimicrobial activity against Escherichia coli AG100A after 18 hrs by rapid INT colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
11616,,3483157,CHEMBL1265796,Antimicrobial activity against Escherichia coli AG100A after 18 hrs by rapid INT colorimetric assay in presence of efflux pump inhibitor phenylalanine arginine,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,0.007,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.007
11617,,3483158,CHEMBL1265797,Antimicrobial activity against tetracycline-resistant Escherichia coli AG100A after 18 hrs by rapid INT colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
11618,,3483159,CHEMBL1265798,Antimicrobial activity against tetracycline-resistant Escherichia coli AG100A after 18 hrs by rapid INT colorimetric assay in presence of efflux pump inhibitor phenylalanine arginine,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
11619,,3483160,CHEMBL1265799,Antimicrobial activity against tetracycline-resistant Escherichia coli AG102 after 18 hrs by rapid INT colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
11620,,3483161,CHEMBL1265800,Antimicrobial activity against tetracycline-resistant Escherichia coli AG102 after 18 hrs by rapid INT colorimetric assay in presence of efflux pump inhibitor phenylalanine arginine,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
11621,,3483162,CHEMBL1265801,Antimicrobial activity against Enterobacter aerogenes ATCC 13048 after 18 hrs by rapid INT colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,0.25
11622,,3483163,CHEMBL1265802,Antimicrobial activity against Enterobacter aerogenes ATCC 13048 after 18 hrs by rapid INT colorimetric assay in presence of efflux pump inhibitor phenylalanine arginine,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,0.25
11623,,3483164,CHEMBL1265948,Antimicrobial activity against Enterobacter aerogenes EA-CM64 after 18 hrs by rapid INT colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,4.0
11624,,3483165,CHEMBL1265949,Antimicrobial activity against Enterobacter aerogenes EA-CM64 after 18 hrs by rapid INT colorimetric assay in presence of efflux pump inhibitor phenylalanine arginine,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,2.0
11625,,3483166,CHEMBL1265950,Antimicrobial activity against Enterobacter aerogenes EA289 after 18 hrs by rapid INT colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,128.0
11626,,3483167,CHEMBL1265951,Antimicrobial activity against Enterobacter aerogenes EA289 after 18 hrs by rapid INT colorimetric assay in presence of efflux pump inhibitor phenylalanine arginine,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,128.0
11627,,3483168,CHEMBL1265952,Antimicrobial activity against Enterobacter aerogenes EA294 after 18 hrs by rapid INT colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,64.0
11628,,3483169,CHEMBL1265953,Antimicrobial activity against Enterobacter aerogenes EA294 after 18 hrs by rapid INT colorimetric assay in presence of efflux pump inhibitor phenylalanine arginine,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,32.0
11629,,3483170,CHEMBL1265954,Antimicrobial activity against Enterobacter aerogenes EA298 after 18 hrs by rapid INT colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,8.0
11630,,3483171,CHEMBL1265955,Antimicrobial activity against Enterobacter aerogenes EA298 after 18 hrs by rapid INT colorimetric assay in presence of efflux pump inhibitor phenylalanine arginine,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,8.0
11631,,3483172,CHEMBL1265956,Antimicrobial activity against Enterobacter aerogenes EA27 after 18 hrs by rapid INT colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,256.0
11632,,3483173,CHEMBL1265957,Antimicrobial activity against Enterobacter aerogenes EA27 after 18 hrs by rapid INT colorimetric assay in presence of efflux pump inhibitor phenylalanine arginine,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,128.0
11633,,3483174,CHEMBL1265958,Antimicrobial activity against Enterobacter aerogenes EA3 after 18 hrs by rapid INT colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,128.0
11634,,3483175,CHEMBL1266463,Antimicrobial activity against Enterobacter aerogenes EA3 after 18 hrs by rapid INT colorimetric assay in presence of efflux pump inhibitor phenylalanine arginine,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,64.0
11635,,3483176,CHEMBL1266464,Antimicrobial activity against Enterobacter aerogenes EA5 after 18 hrs by rapid INT colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,256.0
11636,,3483177,CHEMBL1266465,Antimicrobial activity against Enterobacter aerogenes EA5 after 18 hrs by rapid INT colorimetric assay in presence of efflux pump inhibitor phenylalanine arginine,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,128.0
11637,,3483178,CHEMBL1266466,Antimicrobial activity against Klebsiella pneumoniae ATCC 11296 after 18 hrs by rapid INT colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
11638,,3483179,CHEMBL1266467,Antimicrobial activity against Klebsiella pneumoniae ATCC 11296 after 18 hrs by rapid INT colorimetric assay in presence of efflux pump inhibitor phenylalanine arginine,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.5
11639,,3483180,CHEMBL1266468,Antimicrobial activity against Klebsiella pneumoniae KP55 after 18 hrs by rapid INT colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
11640,,3483181,CHEMBL1266469,Antimicrobial activity against Klebsiella pneumoniae KP55 after 18 hrs by rapid INT colorimetric assay in presence of efflux pump inhibitor phenylalanine arginine,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
11641,,3483182,CHEMBL1266470,Antimicrobial activity against Klebsiella pneumoniae KP63 after 18 hrs by rapid INT colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
11642,,3483183,CHEMBL1266471,Antimicrobial activity against Klebsiella pneumoniae KP63 after 18 hrs by rapid INT colorimetric assay in presence of efflux pump inhibitor phenylalanine arginine,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
11643,,3483184,CHEMBL1266472,Antimicrobial activity against Pseudomonas aeruginosa PAO1 after 18 hrs by rapid INT colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
11644,,3483185,CHEMBL1266473,Antimicrobial activity against Pseudomonas aeruginosa PAO1 after 18 hrs by rapid INT colorimetric assay in presence of efflux pump inhibitor phenylalanine arginine,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
11645,,3483186,CHEMBL1266474,Antimicrobial activity against Pseudomonas aeruginosa PA124 after 18 hrs by rapid INT colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
11646,,3483187,CHEMBL1266475,Antimicrobial activity against Pseudomonas aeruginosa PA124 after 18 hrs by rapid INT colorimetric assay in presence of efflux pump inhibitor phenylalanine arginine,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,32.0
11647,,3483188,CHEMBL1266476,Antimicrobial activity against Enterobacter cloacae Ec07769 after 18 hrs by rapid INT colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,256.0
11648,,3483189,CHEMBL1266477,Antimicrobial activity against Enterobacter cloacae Ec07769 after 18 hrs by rapid INT colorimetric assay in presence of efflux pump inhibitor phenylalanine arginine,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,256.0
11649,,3483190,CHEMBL1266478,Antimicrobial activity against Enterobacter cloacae Ec1194 after 18 hrs by rapid INT colorimetric assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,32.0
11650,,3483191,CHEMBL1266479,Antimicrobial activity against Enterobacter cloacae Ec1194 after 18 hrs by rapid INT colorimetric assay in presence of efflux pump inhibitor phenylalanine arginine,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255429,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961659,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,32.0
11651,Active,3485421,CHEMBL1266127,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate OC12501 assessed as >= 4 fold increase in bactericidal activity by broth microdilution method in presence of 20 ug/ml reserpine,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,960032,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
11652,Active,3485423,CHEMBL1266128,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate OC8530 harboring gyrA S84L and parC I143V mutant gene assessed as >= 4 fold increase in bactericidal activity by broth microdilution method in presence of 20 ug/ml reserpine,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,960032,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
11653,Active,3485425,CHEMBL1266129,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate OC4222 harboring gyrA S84L and parC S80F mutant gene assessed as >= 4 fold increase in bactericidal activity by broth microdilution method in presence of 20 ug/ml reserpine,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,960032,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
11654,Active,3485427,CHEMBL1266130,"Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate OC17042 harboring gyrA S84L/G106D, parC S80F and parE D732N mutant gene assessed as >= 4 fold increase in bactericidal activity by broth microdilution method in presence of 20 ug/ml reserpine",F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,960032,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
11655,Active,3485429,CHEMBL1266131,"Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate OC11521 harboring gyrA S84L/S85P, parC E84G mutant gene assessed as >= 4 fold increase in bactericidal activity by broth microdilution method in presence of 20 ug/ml reserpine",F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,960032,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
11656,Active,3488995,CHEMBL1266126,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate OC11696 assessed as >= 4 fold increase in bactericidal activity by broth microdilution method in presence of 20 ug/ml reserpine,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,960032,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
11657,Active,3488996,CHEMBL1266125,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate OC8525 harboring wild type quinolone resistance-determining region assessed as >= 4 fold increase in bactericidal activity by broth microdilution method in presence of 20 ug/ml reserpine,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255444,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,960032,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
11658,,3492867,CHEMBL1262612,Antibacterial activity against Escherichia coli 10418 after 18 hrs by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255267,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961317,=,1,1,=,MIC,ug.mL-1,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,0.02
11659,,3492868,CHEMBL1262613,Antibacterial activity against Proteus mirabilis B2 after 18 hrs by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255267,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961317,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,mg/L,UO_0000274,0.05
11660,,3492869,CHEMBL1262614,Antibacterial activity against Proteus mirabilis M 44 mutant after 18 hrs by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255267,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961317,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,mg/L,UO_0000274,0.05
11661,,3492870,CHEMBL1262615,Antibacterial activity against Proteus mirabilis M 48 mutant after 18 hrs by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255267,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961317,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,mg/L,UO_0000274,0.05
11662,,3492871,CHEMBL1262616,Antibacterial activity against Proteus mirabilis M 55 mutant after 18 hrs by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255267,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961317,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,mg/L,UO_0000274,0.05
11663,,3492872,CHEMBL1262617,Antibacterial activity against Proteus mirabilis NP14 after 18 hrs by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255267,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961317,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,mg/L,UO_0000274,0.25
11664,,3492873,CHEMBL1262618,Antibacterial activity against Proteus mirabilis M 19 mutant after 18 hrs by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255267,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961317,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,mg/L,UO_0000274,0.19
11665,,3492874,CHEMBL1262619,Antibacterial activity against Proteus mirabilis M 21 mutant after 18 hrs by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255267,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961317,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,mg/L,UO_0000274,0.19
11666,,3492875,CHEMBL1262620,Antibacterial activity against Proteus mirabilis M 23 mutant after 18 hrs by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255267,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961317,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,mg/L,UO_0000274,0.19
11667,,3492876,CHEMBL1262621,Antibacterial activity against Proteus mirabilis NP37 after 18 hrs by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255267,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961317,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,mg/L,UO_0000274,0.05
11668,,3492877,CHEMBL1263127,Antibacterial activity against Proteus mirabilis M 26 mutant after 18 hrs by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255267,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961317,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,mg/L,UO_0000274,0.03
11669,,3492878,CHEMBL1262623,Antibacterial activity against Proteus mirabilis M 29 mutant after 18 hrs by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255267,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961317,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,mg/L,UO_0000274,0.03
11670,,3492879,CHEMBL1262624,Antibacterial activity against Proteus mirabilis M 31 mutant after 18 hrs by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255267,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961317,=,1,1,=,MIC,ug.mL-1,0.02,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,mg/L,UO_0000274,0.02
11671,,3492880,CHEMBL1262625,Antibacterial activity against Proteus mirabilis NP43 after 18 hrs by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255267,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961317,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,mg/L,UO_0000274,0.05
11672,,3492881,CHEMBL1262626,Antibacterial activity against Proteus mirabilis M 12 mutant after 18 hrs by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255267,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961317,=,1,1,=,MIC,ug.mL-1,0.02,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,mg/L,UO_0000274,0.02
11673,,3492882,CHEMBL1262765,Antibacterial activity against Proteus mirabilis M 17 mutant after 18 hrs by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255267,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961317,=,1,1,=,MIC,ug.mL-1,0.02,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,mg/L,UO_0000274,0.02
11674,,3492883,CHEMBL1262766,Antibacterial activity against Proteus mirabilis NP55 after 18 hrs by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255267,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961317,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,mg/L,UO_0000274,0.05
11675,,3492884,CHEMBL1262767,Antibacterial activity against Proteus mirabilis M 35 mutant after 18 hrs by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255267,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961317,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,mg/L,UO_0000274,0.03
11676,,3492885,CHEMBL1262768,Antibacterial activity against Proteus mirabilis M 40 mutant after 18 hrs by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255267,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961317,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,mg/L,UO_0000274,0.03
11677,,3492886,CHEMBL1262769,Antibacterial activity against Proteus mirabilis M 42 mutant after 18 hrs by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255267,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,961317,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,mg/L,UO_0000274,0.03
11678,Active,3496476,CHEMBL1264914,Antibacterial activity against uropathogenic Escherichia coli UTI89 infected in human 5637 cells assessed as decrease in intracellular bacterial level at 300 to 500 ug/ml after 12 hrs by serial dilution method,F,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255465,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Percent,960586,,1,0,,Inhibition,%,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,INH,,UO_0000187,
11679,Active,3496525,CHEMBL1265417,Antibacterial activity against uropathogenic Escherichia coli UTI89 assessed as degradation of preexisting biofilm after 24 hrs by microscopy,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1255465,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,960586,,1,0,,Activity,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,,,
11680,,3518673,CHEMBL1274280,Antimicrobial activity against Staphylococcus aureus by agar plate disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1268823,Bioorg Med Chem Lett,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,966459,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,10.0
11681,,3518685,CHEMBL1274281,Antimicrobial activity against Streptococcus pyogenes by agar plate disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1268823,Bioorg Med Chem Lett,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,966459,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,10.0
11682,,3518697,CHEMBL1274282,Antimicrobial activity against Escherichia coli by agar plate disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1268823,Bioorg Med Chem Lett,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,966459,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,10.0
11683,,3518709,CHEMBL1274283,Antimicrobial activity against Pseudomonas aeruginosa by agar plate disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1268823,Bioorg Med Chem Lett,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,966459,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,10.0
11684,,3534003,CHEMBL1280221,"Antimicrobial activity against Escherichia coli BicA expressing blaTEM-1, blaCTX-M-15 and qepA2 gene by disk diffusion method",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275501,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969952,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
11685,,3534030,CHEMBL1280222,Antimicrobial activity against azide-resistant Escherichia coli J53 harboring pCTX-M plasmid carrying blaCTX-M-15 gene by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275501,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969952,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
11686,,3534057,CHEMBL1280223,Antimicrobial activity against azide-resistant Escherichia coli J53 harboring pCTX-M carrying blaCTX-M-15 and pQep plasmid carrying qepA2 gene by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275501,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969952,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
11687,,3534084,CHEMBL1280224,Antimicrobial activity against azide-resistant Escherichia coli J53 by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275501,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969952,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
11688,,3534111,CHEMBL1280225,Antimicrobial activity against Escherichia coli TOP10 harboring pQep plasmid carrying qepA2 gene by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275501,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969952,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
11689,,3534138,CHEMBL1280226,Antimicrobial activity against Escherichia coli TOP10 by disk diffusion method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275501,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969952,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
11690,,3534780,CHEMBL1286720,Antimicrobial activity against beta-lactamase CTX-M-15-producing fluoroquinolone-resistant Escherichia coli FMV5825 expressing qnrB2 and aac(6')-Ib-cr and harboring gyrA Ser83Ile and Asp87Asn mutant gene and ParC Ser80Ile and Glu84Val mutant gene obtained from dog with urinary tract infection by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275581,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969981,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
11691,,3534802,CHEMBL1286723,Antimicrobial activity against Azide-resistant Escherichia coli J53 transconjugant harboring Escherichia coli DH5alpha-5825 qnrB2 gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275581,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969981,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
11692,,3534824,CHEMBL1286726,Antimicrobial activity against Azide-resistant Escherichia coli J53 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275581,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969981,=,1,1,=,MIC,ug.mL-1,0.062,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.062
11693,,3535316,CHEMBL1281176,Antimicrobial activity against Escherichia coli TOP10 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275505,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969955,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.032
11694,,3535317,CHEMBL1281177,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr1 carrying Smqnr gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275505,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969955,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.064
11695,,3535318,CHEMBL1281178,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr2 carrying Smqnr gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275505,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969955,=,1,1,=,MIC,ug.mL-1,0.047,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.047
11696,,3535319,CHEMBL1281179,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr3 carrying Smqnr gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275505,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969955,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.032
11697,,3535320,CHEMBL1281180,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr4 carrying Smqnr gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275505,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969955,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.032
11698,,3535321,CHEMBL1281181,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr5 carrying Smqnr gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275505,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969955,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.032
11699,,3535322,CHEMBL1281182,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr6 carrying Smqnr gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275505,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969955,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.064
11700,,3535323,CHEMBL1281183,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr7 carrying Smqnr gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275505,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969955,=,1,1,=,MIC,ug.mL-1,0.047,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.047
11701,,3535324,CHEMBL1281184,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr8 carrying Smqnr gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275505,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969955,=,1,1,=,MIC,ug.mL-1,0.047,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.047
11702,,3535325,CHEMBL1281185,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr9 carrying Smqnr gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275505,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969955,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.032
11703,,3535326,CHEMBL1281186,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr10 carrying Smqnr gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275505,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969955,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.032
11704,,3535327,CHEMBL1281187,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr11 carrying Smqnr gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275505,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969955,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.032
11705,,3542398,CHEMBL1282981,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275528,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970124,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
11706,,3542399,CHEMBL1282989,Antimicrobial activity against Salmonella serovar Typhimurium LT2 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275528,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970124,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,0.06
11707,,3542400,CHEMBL1282990,Antimicrobial activity against Salmonella serovar Typhimurium 14028S by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275528,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970124,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,0.06
11708,,3542401,CHEMBL1282991,Antimicrobial activity against Salmonella serovar Binza 8269 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275528,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970124,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
11709,,3542402,CHEMBL1282992,Antimicrobial activity against Salmonella serovar Enteritidis 5188 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275528,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970124,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614447,Salmonella enterica subsp. enterica serovar Enteritidis,Salmonella enteritidis,149539.0,,MIC,ug ml-1,UO_0000274,0.06
11710,,3542403,CHEMBL1283729,Antimicrobial activity against Salmonella serovar Hadar by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275528,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970124,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
11711,,3542404,CHEMBL1283730,Antimicrobial activity against Salmonella serovar Heidelberg 5171 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275528,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970124,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
11712,,3542405,CHEMBL1283731,Antimicrobial activity against Salmonella serovar Haifa 9878 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275528,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970124,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
11713,,3542406,CHEMBL1283732,Antimicrobial activity against Salmonella serovar Kedougou by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275528,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970124,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
11714,,3542407,CHEMBL1283733,Antimicrobial activity against Salmonella serovar Mbandaka 7892 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275528,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970124,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
11715,,3542408,CHEMBL1283734,Antimicrobial activity against Salmonella serovar Montevideo 5747 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275528,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970124,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
11716,,3542409,CHEMBL1283735,Antimicrobial activity against Salmonella serovar Newport 129 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275528,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970124,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
11717,,3542410,CHEMBL1283881,Antimicrobial activity against Salmonella serovar Virchow 5742 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275528,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970124,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
11718,,3542436,CHEMBL1282988,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph mutant by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275528,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970124,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.25
11719,,3542446,CHEMBL1283882,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 by broth dilution method in presence of chlorpromazine,F,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275528,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970124,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.008
11720,Not Determined,3542457,CHEMBL1283883,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph mutant by broth dilution method in presence of chlorpromazine,F,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275528,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,970124,,1,0,,MIC,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,,,
11721,,3542468,CHEMBL1283884,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph-pTRC hisA:ramA mutant by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275528,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970124,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.25
11722,,3542479,CHEMBL1283885,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph-pTRC hisA:ramA mutant by broth dilution method in presence of IPTG,F,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275528,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970124,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.25
11723,,3542489,CHEMBL1283886,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph-pTRC hisA:ramA mutant by broth dilution method in presence of chlorpromzine,F,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275528,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970124,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.25
11724,,3543683,CHEMBL1285182,Antibacterial activity against Bacillus subtilis ATCC 60511 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275278,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970561,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,1.0
11725,,3543685,CHEMBL1285181,Antibacterial activity against Klebsiella pneumoniae ATCC 10031 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275278,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970561,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
11726,,3543687,CHEMBL1285180,Antibacterial activity against Escherichia coli ATCC 10536 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275278,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970561,<=,1,1,<=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
11727,,3543693,CHEMBL1285184,Antibacterial activity against Staphylococcus aureus ATCC 11632 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275278,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970561,<=,1,1,<=,MIC,ug.mL-1,5.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,5.0
11728,,3543695,CHEMBL1285183,Antibacterial activity against Streptococcus faecalis ATCC 14506 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275278,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970561,<=,1,1,<=,MIC,ug.mL-1,5.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,5.0
11729,,3543697,CHEMBL1285179,Antibacterial activity against Pseudomonas aeruginosa ATCC 10145 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275278,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970561,<=,1,1,<=,MIC,ug.mL-1,5.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,5.0
11730,,3544349,CHEMBL1284061,Antimicrobial activity against rmtB positive Escherichia coli VOG producing beta lactamase CTX-M-14 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275569,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970289,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
11731,,3544350,CHEMBL1284062,"Antimicrobial activity against Escherichia coli TOP10 harboring plasmid VOG1 expressing RmtB, TEM-1, and QepA gene by Etest method",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275569,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970289,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.032
11732,,3544351,CHEMBL1284063,Antimicrobial activity against Escherichia coli TOP10 harboring plasmid VOG2 expressing CTX-M-14 and AAC(6 )-Ib gene by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275569,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970289,<,1,1,<,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
11733,,3544352,CHEMBL1284064,Antimicrobial activity against armB positive Escherichia coli COP producing beta lactamase CTX-M-14 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275569,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970289,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
11734,,3544353,CHEMBL1284065,Antimicrobial activity against armA positive Escherichia coli TOP10 harboring plasmid COP1 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275569,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970289,<,1,1,<,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
11735,,3544354,CHEMBL1284066,Antimicrobial activity against beta lactamase CTX-M-14 producing Escherichia coli TOP10 harboring plasmid COP2 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275569,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970289,<,1,1,<,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
11736,,3544355,CHEMBL1284067,Antimicrobial activity against armA positive Escherichia coli MEZ producing beta lactamase CTX-M-3 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275569,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970289,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
11737,,3544356,CHEMBL1284068,Antimicrobial activity against armA positive Escherichia coli TOP10 producing beta lactamase CTX-M-3 with plasmid MEZ by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275569,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970289,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
11738,,3544357,CHEMBL1284069,Antimicrobial activity against armA positive Enterobacter cloacae BEH producing beta lactamase CTX-M-3 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275569,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970289,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,1.0
11739,,3544358,CHEMBL1284070,Antimicrobial activity against armA positive Escherichia coli TOP10 producing beta lactamase CTX-M-3 with plasmid BEH by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275569,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970289,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
11740,,3544359,CHEMBL1284071,Antimicrobial activity against armA positive Klebsiella pneumoniae DU producing beta lactamase CTX-M-3 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275569,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970289,=,1,1,=,MIC,ug.mL-1,0.75,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.75
11741,,3544360,CHEMBL1284072,Antimicrobial activity against armA positive Escherichia coli TOP10 producing beta lactamase CTX-M-3 with plasmid DU by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275569,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970289,=,1,1,=,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
11742,,3544361,CHEMBL1284073,Antimicrobial activity against Escherichia coli TOP10 by Etest method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275569,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970289,<,1,1,<,MIC,ug.mL-1,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.016
11743,,3545909,CHEMBL1280566,Antimicrobial activity against Citrobacter werkmanii PS012 expressing PMQR determinant qnrB22 gene by Etest,F,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275241,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970840,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.5
11744,,3545910,CHEMBL1280567,Antimicrobial activity against Citrobacter freundii S008 expressing PMQR determinant qnrB23 gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275241,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970840,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,8.0
11745,,3545911,CHEMBL1280568,Antimicrobial activity against azide-resistant Escherichia coli J53 TrcPS012 harboring PMQR determinant qnrB22 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275241,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970840,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
11746,,3545912,CHEMBL1280569,Antimicrobial activity against azide-resistant Escherichia coli J53 TrcS008 harboring PMQR determinant qnrB23 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275241,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970840,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
11747,,3545913,CHEMBL1280570,Antimicrobial activity against azide-resistant Escherichia coli J53 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275241,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970840,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.064
11748,,3545914,CHEMBL1280571,Antimicrobial activity against azide-resistant Escherichia coli DH5alpha TrfPS012 harboring PMQR determinant qnrB22 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275241,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970840,=,1,1,=,MIC,ug.mL-1,0.064,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.064
11749,,3545915,CHEMBL1280572,Antimicrobial activity against azide-resistant Escherichia coli DH5alpha TrfS008 harboring PMQR determinant qnrB23 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275241,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970840,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
11750,,3545916,CHEMBL1280573,Antimicrobial activity against azide-resistant Escherichia coli DH5alpha by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275241,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,970840,=,1,1,=,MIC,ug.mL-1,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.032
11751,,3550444,CHEMBL1284784,Antimicrobial activity against Burkholderia pseudomallei Bp207 harboring deleted (bpeAB-oprA)::FRT gene after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275254,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,971077,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,0.25
11752,,3550445,CHEMBL1284775,Antimicrobial activity against Burkholderia pseudomallei Bp216 harboring mini-Tn7T after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275254,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,971077,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,0.25
11753,,3550464,CHEMBL1284783,Antimicrobial activity against Burkholderia pseudomallei Bp175 harboring mini-Tn7T-P1-bpeR+ after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275254,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,971077,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,1.0
11754,,3550484,CHEMBL1284779,Antimicrobial activity against Burkholderia pseudomallei Bp227 harboring deleted (bpeAB-oprA)::FRT gene after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275254,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,971077,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,2.0
11755,,3550501,CHEMBL1284777,Antimicrobial activity against Burkholderia pseudomallei 1026b after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275254,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,971077,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,4.0
11756,,3550502,CHEMBL1284778,Antimicrobial activity against Burkholderia pseudomallei Bp50 harboring deleted (amrRAB-oprA)::FRT gene after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275254,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,971077,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,4.0
11757,,3550503,CHEMBL1284776,Antimicrobial activity against Burkholderia pseudomallei Bp250 harboring mini-Tn7T-bpeA+B+ -oprB+ after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275254,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,971077,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,4.0
11758,,3550519,CHEMBL1284782,Antimicrobial activity against Burkholderia pseudomallei Bp174 harboring mini-Tn7T-bpeR+ after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275254,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,971077,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,8.0
11759,,3550534,CHEMBL1284780,Antimicrobial activity against Burkholderia pseudomallei Bp58 harboring deleted bpeR::FRT gene after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275254,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,971077,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,16.0
11760,,3550535,CHEMBL1284781,Antimicrobial activity against Burkholderia pseudomallei Bp173 harboring mini-Tn7T after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275254,Antimicrob Agents Chemother,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,971077,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL3140323,Burkholderia pseudomallei,Burkholderia pseudomallei,28450.0,,MIC,ug ml-1,UO_0000274,16.0
11761,,3567873,CHEMBL1278659,Antibacterial activity against Pseudomonas aeruginosa 100609 after 20 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275410,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969561,=,1,1,=,MIC,ug.mL-1,15.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,15.0
11762,,3567893,CHEMBL1278660,Antibacterial activity against Pseudomonas aeruginosa 100609 after 20 hrs by broth microdilution assay in presence of 250 ug/ml polyethylenimine,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275410,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969561,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,10.0
11763,,3567913,CHEMBL1278661,"FIC index, ratio of MIC for Pseudomonas aeruginosa 100609 in presence of 250 ug/ml polyethylenimine to MIC for Pseudomonas aeruginosa 100609",F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275410,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,969561,=,1,0,=,FICI,,0.68,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,FICI,,,0.68
11764,,3569385,CHEMBL1278946,Antimicrobial activity against QnrS2-negative Aeromonas veronii CECT 4258 harboring GyrA Ser83 and ParC Ser80 mutant gene by Etest,F,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275465,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969698,<,1,1,<,MIC,ug.mL-1,0.02,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,mg/L,UO_0000274,0.02
11765,,3569388,CHEMBL1278947,Antimicrobial activity against QnrS2-negative Aeromonas veronii CECT 4260 harboring GyrA Ser83 and ParC Ser80 mutant gene by Etest,F,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275465,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969698,<,1,1,<,MIC,ug.mL-1,0.02,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,mg/L,UO_0000274,0.02
11766,,3569391,CHEMBL1278948,Antimicrobial activity against QnrS2-positive Aeromonas veronii A272 harboring GyrA Ile83 and ParC Ile80 mutant gene by Etest,F,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275465,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969698,=,1,1,=,MIC,ug.mL-1,12.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,mg/L,UO_0000274,12.0
11767,,3569394,CHEMBL1278949,Antimicrobial activity against Escherichia coli J53 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275465,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969698,=,1,1,=,MIC,ug.mL-1,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,0.19
11768,,3569397,CHEMBL1278950,Antimicrobial activity against Escherichia coli J53 harboring QnrS2 and GyrA Ile83 and ParC Ile80 mutant gene by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275465,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969698,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,mg/L,UO_0000274,2.0
11769,,3569526,CHEMBL1279215,"Antimicrobial activity against Klebsiella pneumoniae containing PFGE clone A expressing beta-lactamase Oxa-48, TEM-1, SHV-12 and Oxa-9 by Etest",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275467,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969702,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
11770,,3569537,CHEMBL1279216,"Antimicrobial activity against Klebsiella pneumoniae containing PFGE clone B expressing beta-lactamase Oxa-48, TEM-1, CTX-M-15 and Oxa-1 by Etest",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275467,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969702,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,256.0
11771,,3570363,CHEMBL1278388,Antimicrobial activity against Escherichia coli R4525 expressing gyrA S83L and D87Y and parC S80I and E84G mutant gene by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275471,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969821,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,256.0
11772,,3570364,CHEMBL1278389,Antimicrobial activity against Escherichia coli J53 transconjugate by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275471,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969821,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
11773,,3570365,CHEMBL1278390,Antimicrobial activity against azide-resistant Escherichia coli J53 by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275471,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969821,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.12
11774,,3571504,CHEMBL1280544,Antibacterial activity against Staphylococcus aureus RN4220 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275477,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969844,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
11775,,3571505,CHEMBL1281302,Antimicrobial activity against Staphylococcus aureus 286607-R1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275477,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969844,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
11776,,3571506,CHEMBL1281303,Antimicrobial activity against Staphylococcus aureus 286607-R1 harboring wild type gyrB by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275477,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969844,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
11777,,3571507,CHEMBL1281304,Antimicrobial activity against Staphylococcus aureus RN4220 expressing gyrB D437N mutant gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1275477,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,969844,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
11778,Active,4128730,CHEMBL1614455,"PUBCHEM_BIOASSAY: A Counter Screen to identiry small molecule screen for inhibitors of the PhoP region in Salmonella Typhimurium. (Class of assay: confirmatory) [Related pubchem assays: 2253, 1863, 1981, 1874 ]",F,BAO_0000190,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1201862,,,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,1297959,=,7,1,=,IC50,nM,880.0,CHEMBL612545,,Unchecked,,,IC50,um,UO_0000065,0.88
11779,Inconclusive,4276406,CHEMBL1614459,PUBCHEM_BIOASSAY: qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells. (Class of assay: confirmatory) ,F,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1201862,,,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,1297959,=,7,1,=,Potency,nM,18356.4,CHEMBL612545,,Unchecked,,,Potency,um,UO_0000065,18.3564
11780,Active,4303862,CHEMBL1614127,"PUBCHEM_BIOASSAY: A screen for inhibitors of the PhoP region in Salmonella Typhimurium using a modified counterscreen. (Class of assay: confirmatory) [Related pubchem assays: 2253, 1863, 1874 ]",F,BAO_0000190,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1201862,,,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,1297959,=,7,1,=,IC50,nM,890.0,CHEMBL612545,,Unchecked,,,IC50,um,UO_0000065,0.89
11781,Active,4421030,CHEMBL1614183,PUBCHEM_BIOASSAY: High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv. (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1201862,,,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,1297959,=,7,1,=,IC50,nM,2845.0,CHEMBL612545,,Unchecked,,,IC50,um,UO_0000065,2.845
11782,Active,4643536,CHEMBL1613791,"PUBCHEM_BIOASSAY: A counter screen for small molecule screen for inhibitors of the PhoP region in Salmonella typhi. (Class of assay: confirmatory) [Related pubchem assays: 1850, 1864, 2252, 1985 ]",F,BAO_0000190,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1201862,,,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,1297959,=,7,1,=,IC50,nM,490.0,CHEMBL612545,,Unchecked,,,IC50,um,UO_0000065,0.49
11783,Active,4686438,CHEMBL1613789,"PUBCHEM_BIOASSAY: A small molecule screen for inhibitors of the PhoP region in Salmonella Typhimurium. (Class of assay: confirmatory) [Related pubchem assays: 2253, 1981, 1874 ]",F,BAO_0000190,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1201862,,,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,1297959,=,7,1,=,IC50,nM,510.0,CHEMBL612545,,Unchecked,,,IC50,um,UO_0000065,0.51
11784,Active,5004899,CHEMBL1614100,"PUBCHEM_BIOASSAY: A small molecule screen for inhibitors of the PhoP region in Salmonella typhi. (Class of assay: confirmatory) [Related pubchem assays: 1864, 2252, 1985 ]",F,BAO_0000190,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1201862,,,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,1297959,=,7,1,=,IC50,nM,270.0,CHEMBL612545,,Unchecked,,,IC50,um,UO_0000065,0.27
11785,Active,5012662,CHEMBL1613923,"PUBCHEM_BIOASSAY: A cytotoxicity screen of small molecule inhibitors of the PhoP region in Salmonella typhi identified in the primary screen. (Class of assay: confirmatory) [Related pubchem assays: 1850, 1864, 1985 ]",F,BAO_0000188,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1201862,,,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,1297959,>,7,1,>,EC50,nM,50000.0,CHEMBL612545,,Unchecked,,,EC50,um,UO_0000065,50.0
11786,Active,5020805,CHEMBL1613892,PUBCHEM_BIOASSAY: A screen for inhibitors of the PhoP region in Salmonella Typhi using a modified counterscreen. (Class of assay: confirmatory) ,F,BAO_0000190,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1201862,,,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/Nanomolar,1297959,<,7,1,<,IC50,nM,230.0,CHEMBL612545,,Unchecked,,,IC50,um,UO_0000065,0.23
11787,,5085039,CHEMBL1636907,Antibacterial activity against Streptococcus pneumoniae U2A1686 harboring gyrA Glu85Lys mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312951,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
11788,,5085040,CHEMBL1636906,Antibacterial activity against Streptococcus pneumoniae R6 Tr6 harboring gyrA Ser81Phe mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312951,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
11789,,5085041,CHEMBL1636905,Antibacterial activity against Streptococcus pneumoniae CP1000 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312951,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
11790,,5085042,CHEMBL1636904,Antibacterial activity against Streptococcus pneumoniae R6 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312951,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
11791,,5085043,CHEMBL1636903,Antibacterial activity against Streptococcus pneumoniae CIP104485 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312951,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
11792,,5085914,CHEMBL1634880,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, Y87 and parC K84 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313903,=,1,1,=,MIC,ug.mL-1,1000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1000.0
11793,,5085915,CHEMBL1634878,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83,N87,gyrB V456, parC I80 and parE A458 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313903,=,1,1,=,MIC,ug.mL-1,700.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,700.0
11794,,5085916,CHEMBL1634879,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, Y87 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313903,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
11795,,5085917,CHEMBL1634877,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87, parC I80, K84 and parE D460 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313903,=,1,1,=,MIC,ug.mL-1,400.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,400.0
11796,,5085918,CHEMBL1634876,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87, gyrB T471 and parC I80, G84 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313903,=,1,1,=,MIC,ug.mL-1,200.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,200.0
11797,,5085919,CHEMBL1634875,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87 and parC R80, V84 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313903,=,1,1,=,MIC,ug.mL-1,700.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,700.0
11798,,5085920,CHEMBL1634873,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87, parC I80 and parE A548 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313903,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,50.0
11799,,5085921,CHEMBL1634874,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87 and parC I80, G84 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313903,=,1,1,=,MIC,ug.mL-1,200.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,200.0
11800,,5085922,CHEMBL1634872,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87, parC I80 and parE M464 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313903,=,1,1,=,MIC,ug.mL-1,400.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,400.0
11801,,5085923,CHEMBL1634871,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87 and parC I80 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313903,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,10.0
11802,,5085924,CHEMBL1634870,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87 and parC K84 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313903,=,1,1,=,MIC,ug.mL-1,200.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,200.0
11803,,5085925,CHEMBL1634869,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, N87 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313903,=,1,1,=,MIC,ug.mL-1,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,10.0
11804,,5085926,CHEMBL1634866,Antimicrobial activity against Escherichia coli K-12 harboring gyrA A83 mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313903,=,1,1,=,MIC,ug.mL-1,0.194,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.194
11805,,5085927,CHEMBL1634868,Antimicrobial activity against Escherichia coli K-12 harboring parE A458 mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313903,=,1,1,=,MIC,ug.mL-1,0.047,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.047
11806,,5085929,CHEMBL1634867,Antimicrobial activity against Escherichia coli K-12 harboring by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313903,=,1,1,=,MIC,ug.mL-1,0.023,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.023
11807,,5085986,CHEMBL1634881,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, Y87 and parC I80 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313903,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,50.0
11808,,5085987,CHEMBL1634882,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, Y87, parC I80 and parE A458 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313903,=,1,1,=,MIC,ug.mL-1,300.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,300.0
11809,,5085988,CHEMBL1634883,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, Y87 and parC I80, G84 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313903,=,1,1,=,MIC,ug.mL-1,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,100.0
11810,,5085989,CHEMBL1634884,"Antimicrobial activity against Escherichia coli K-12 harboring gyrA L83, Y87, parC I80, G84 and parE A458 mutant gene by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629564,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313903,=,1,1,=,MIC,ug.mL-1,1000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1000.0
11811,,5085990,CHEMBL1634886,Antimicrobial activity against fluoroquinolone-sensitive Escherichia coli clinical isolate by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629565,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313907,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
11812,,5086006,CHEMBL1634885,Antimicrobial activity against Escherichia coli ATCC 25922 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629565,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313907,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
11813,,5086007,CHEMBL1634886,Antimicrobial activity against fluoroquinolone-sensitive Escherichia coli clinical isolate by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629565,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313907,=,1,1,=,MIC,ug.mL-1,0.02,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.02
11814,,5086008,CHEMBL1634887,Antimicrobial activity against fluoroquinolone-resistant Escherichia coli clinical isolate by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629565,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313907,=,1,1,=,MIC,ug.mL-1,232.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,232.0
11815,,5086009,CHEMBL1634888,Antimicrobial activity against fluoroquinolone-resistant Escherichia coli clinical isolate by Etest,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629565,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313907,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
11816,Active,5090040,CHEMBL1633425,Antimicrobial activity against Salmonella enterica HN-GSS2006-142 by broth microdilution assay,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629619,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,1314554,,1,0,,Activity,,,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,Activity,,,
11817,Active,5090041,CHEMBL1633426,Antimicrobial activity against Salmonella enterica HN-GSS2007-0.033 by broth microdilution assay,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629619,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,1314554,,1,0,,Activity,,,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,Activity,,,
11818,Active,5090042,CHEMBL1633427,Antimicrobial activity against Salmonella enterica HN-GSS2007-0.056 by broth microdilution assay,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629619,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,1314554,,1,0,,Activity,,,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,Activity,,,
11819,Active,5090043,CHEMBL1633428,Antimicrobial activity against Salmonella enterica HN-GSS-2007-057 by broth microdilution assay,F,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629619,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,1314554,,1,0,,Activity,,,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,Activity,,,
11820,,5090056,CHEMBL1633429,Antimicrobial activity against Escherichia coli DH10B by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629619,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314554,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
11821,,5090057,CHEMBL1633430,Antimicrobial activity against Escherichia coli DH10B harboring pBR322 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629619,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314554,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
11822,,5090058,CHEMBL1633431,Antimicrobial activity against Escherichia coli DH10B harboring pBR322 with Salmonella enterica HN-GSS-2007-057 qnrA1 gene by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629619,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314554,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
11823,,5090059,CHEMBL1633432,Antimicrobial activity against Escherichia coli DH10B harboring pBR322 with Salmonella enterica HN-GSS-2007-057 qnrS1 gene by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629619,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314554,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
11824,,5090060,CHEMBL1633433,Antimicrobial activity against Escherichia coli DH10B harboring pBR322 with Salmonella enterica HN-GSS-2007-057 qnrD gene by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629619,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314554,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
11825,,5090061,CHEMBL1633573,Antimicrobial activity against Escherichia coli DH10B harboring p2007057 by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629619,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314554,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
11826,,5096833,CHEMBL1636921,Antibacterial activity against Streptococcus pneumoniae U2A1414 harboring gyrA Glu85Lys parC Ser79Phe mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312951,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,256.0
11827,,5096834,CHEMBL1636920,Antibacterial activity against Streptococcus pneumoniae U2A1060 harboring gyrA Ser81Phe parC Asp83His mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312951,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,256.0
11828,,5096835,CHEMBL1636917,Antibacterial activity against Streptococcus pneumoniae U2A1681 harboring parC Ser79Tyr Asp83Ala mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312951,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,256.0
11829,,5096836,CHEMBL1636916,Antibacterial activity against Streptococcus pneumoniae U2A1411 harboring parC Asp83Gly mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312951,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,256.0
11830,,5096839,CHEMBL1636919,Antibacterial activity against Streptococcus pneumoniae U2A1056 harboring gyrA Ser81Tyr parC Asp83His mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312951,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,128.0
11831,,5096840,CHEMBL1636918,Antibacterial activity against Streptococcus pneumoniae R6 Tr10 harboring gyrA Ser81Tyr parC Ser79Tyr mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312951,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,128.0
11832,,5096845,CHEMBL1636915,Antibacterial activity against Streptococcus pneumoniae U2A1693 harboring parC Asp83Asn mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312951,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
11833,,5096846,CHEMBL1636913,Antibacterial activity against Streptococcus pneumoniae U2A1053 harboring parC Ser79Phe mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312951,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
11834,,5096847,CHEMBL1636912,Antibacterial activity against Streptococcus pneumoniae R6 Tr1 harboring parC Ser79Tyr mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312951,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,64.0
11835,,5096850,CHEMBL1636914,Antibacterial activity against Streptococcus pneumoniae U2A1413 harboring parC Ser79Tyr mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312951,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
11836,,5096851,CHEMBL1636911,Antibacterial activity against Streptococcus pneumoniae H548 clinical isolate harboring gyrA Ser81Phe mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312951,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,32.0
11837,,5096890,CHEMBL1636739,Antibacterial activity against Streptococcus pneumoniae U2A1686 harboring gyrA Glu85Lys mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,1312951,=,1,1,=,IZ,mm,22.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,22.0
11838,,5096897,CHEMBL1636737,Antibacterial activity against Streptococcus pneumoniae CP1000 by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,1312951,=,1,1,=,IZ,mm,21.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,21.0
11839,,5096909,CHEMBL1636736,Antibacterial activity against Streptococcus pneumoniae R6 by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,1312951,=,1,1,=,IZ,mm,19.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,19.0
11840,,5096910,CHEMBL1636735,Antibacterial activity against Streptococcus pneumoniae CIP104485 by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,1312951,=,1,1,=,IZ,mm,19.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,19.0
11841,,5096917,CHEMBL1636741,Antibacterial activity against Streptococcus pneumoniae U2A1051 harboring gyrA Ser81Tyr mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,1312951,=,1,1,=,IZ,mm,18.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,18.0
11842,,5096918,CHEMBL1636738,Antibacterial activity against Streptococcus pneumoniae R6 Tr6 harboring gyrA Ser81Phe mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,1312951,=,1,1,=,IZ,mm,18.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,18.0
11843,,5096929,CHEMBL1636740,Antibacterial activity against Streptococcus pneumoniae U2A1050 harboring gyrA Ser81Phe mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,1312951,=,1,1,=,IZ,mm,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,16.0
11844,,5096936,CHEMBL1636742,Antibacterial activity against Streptococcus pneumoniae U2A1266 harboring gyrA Ser81Cys mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,1312951,=,1,1,=,IZ,mm,13.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,13.0
11845,,5096951,CHEMBL1636910,Antibacterial activity against Streptococcus pneumoniae U2A1266 harboring gyrA Ser81Cys mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312951,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
11846,,5096952,CHEMBL1636909,Antibacterial activity against Streptococcus pneumoniae U2A1051 harboring gyrA Ser81Tyr mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312951,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
11847,,5096953,CHEMBL1636908,Antibacterial activity against Streptococcus pneumoniae U2A1050 harboring gyrA Ser81Phe mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312951,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
11848,,5096971,CHEMBL1636902,Antibacterial activity against Streptococcus pneumoniae U2A1414 harboring gyrA Glu85Lys parC Ser79Phe mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,1312951,=,1,1,=,IZ,mm,6.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,6.0
11849,,5096972,CHEMBL1636901,Antibacterial activity against Streptococcus pneumoniae U2A1060 harboring gyrA Ser81Phe parC Asp83His mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,1312951,=,1,1,=,IZ,mm,6.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,6.0
11850,,5096973,CHEMBL1636900,Antibacterial activity against Streptococcus pneumoniae U2A1056 harboring gyrA Ser81Tyr parC Asp83His mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,1312951,=,1,1,=,IZ,mm,6.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,6.0
11851,,5096974,CHEMBL1636899,Antibacterial activity against Streptococcus pneumoniae R6 Tr10 harboring gyrA Ser81Tyr parC Ser79Tyr mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,1312951,=,1,1,=,IZ,mm,6.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,6.0
11852,,5096975,CHEMBL1636749,Antibacterial activity against Streptococcus pneumoniae U2A1681 harboring parC Ser79Tyr Asp83Ala mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,1312951,=,1,1,=,IZ,mm,6.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,6.0
11853,,5096976,CHEMBL1636748,Antibacterial activity against Streptococcus pneumoniae U2A1411 harboring parC Asp83Gly mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,1312951,=,1,1,=,IZ,mm,6.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,6.0
11854,,5096977,CHEMBL1636747,Antibacterial activity against Streptococcus pneumoniae U2A1693 harboring parC Asp83Asn mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,1312951,=,1,1,=,IZ,mm,6.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,6.0
11855,,5096978,CHEMBL1636746,Antibacterial activity against Streptococcus pneumoniae U2A1413 harboring parC Ser79Tyr mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,1312951,=,1,1,=,IZ,mm,6.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,6.0
11856,,5096979,CHEMBL1636745,Antibacterial activity against Streptococcus pneumoniae U2A1053 harboring parC Ser79Phe mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,1312951,=,1,1,=,IZ,mm,6.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,6.0
11857,,5096980,CHEMBL1636744,Antibacterial activity against Streptococcus pneumoniae R6 Tr1 harboring parC Ser79Tyr mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,1312951,=,1,1,=,IZ,mm,6.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,6.0
11858,,5096981,CHEMBL1636743,Antibacterial activity against Streptococcus pneumoniae H548 clinical isolate harboring gyrA Ser81Phe mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://qudt.org/vocab/unit#Millimeter,1312951,=,1,1,=,IZ,mm,6.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,6.0
11859,,5111509,CHEMBL1638435,Antibacterial activity against Staphylococcus aureus RN 4220 after 20 hrs by twofold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629475,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1316273,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
11860,,5111510,CHEMBL1638436,Antibacterial activity against Staphylococcus aureus KCTC 503 after 20 hrs by twofold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629475,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1316273,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
11861,,5111511,CHEMBL1638437,Antibacterial activity against Staphylococcus aureus KCTC 209 after 20 hrs by twofold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629475,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1316273,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
11862,,5111512,CHEMBL1638438,Antibacterial activity against Streptococcus mutans KCTC 3065 after 20 hrs by twofold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629475,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1316273,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,MIC,ug ml-1,UO_0000274,1.0
11863,,5111513,CHEMBL1638439,Antibacterial activity against Streptococcus mutans KCTC 3289 after 20 hrs by twofold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629475,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1316273,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,MIC,ug ml-1,UO_0000274,1.0
11864,,5111514,CHEMBL1638440,Antibacterial activity against Escherichia coli 1924 after 20 hrs by twofold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629475,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1316273,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
11865,,5111515,CHEMBL1638441,Antibacterial activity against Escherichia coli 1356 after 20 hrs by twofold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629475,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1316273,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
11866,,5111552,CHEMBL1639207,Antibacterial activity against Staphylococcus aureus MRSA CCARM 3167 after 20 hrs by twofold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629475,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1316273,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
11867,,5111553,CHEMBL1639208,Antibacterial activity against Staphylococcus aureus MRSA CCARM 3506 after 20 hrs by twofold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629475,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1316273,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
11868,,5111554,CHEMBL1639209,Antibacterial activity against Staphylococcus aureus QRSA CCARM 3505 after 20 hrs by twofold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629475,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1316273,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
11869,,5111555,CHEMBL1639210,Antibacterial activity against Staphylococcus aureus QRSA CCARM 3519 after 20 hrs by twofold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629475,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1316273,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
11870,,5117134,CHEMBL1632730,Antimicrobial activity against Cryptococcus neoformans ATCC 14116 after 18 to 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629487,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314829,=,1,1,=,MIC,ug.mL-1,4.88,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,MIC,ug ml-1,UO_0000274,4.88
11871,,5117153,CHEMBL1632729,Antimicrobial activity against Candida albicans ATCC 90028 after 18 to 24 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1629487,Eur J Med Chem,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1314829,=,1,1,=,MIC,ug.mL-1,312.5,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,ug ml-1,UO_0000274,312.5
11872,,5124873,CHEMBL1647721,Antibacterial activity against multi drug-resistant Staphylococcus aureus 1199B after 18 hrs by MTT assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1641398,J Nat Prod,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1317215,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
11873,,5124876,CHEMBL1648265,Antibacterial activity against multi drug-resistant Staphylococcus aureus XU212 after 18 hrs by MTT assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1641398,J Nat Prod,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1317215,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
11874,,5124879,CHEMBL1648266,Antibacterial activity against Staphylococcus aureus ATCC 25943 after 18 hrs by MTT assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1641398,J Nat Prod,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1317215,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
11875,,5124882,CHEMBL1648267,Antibacterial activity against erythromycin-resistant Staphylococcus aureus RN4220 after 18 hrs by MTT assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1641398,J Nat Prod,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1317215,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
11876,,5124885,CHEMBL1648268,Antibacterial activity against epidemic methicillin-resistant Staphylococcus aureus 15 after 18 hrs by MTT assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1641398,J Nat Prod,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1317215,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.5
11877,,5124888,CHEMBL1648269,Antibacterial activity against epidemic methicillin-resistant Staphylococcus aureus 16 after 18 hrs by MTT assay,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1641398,J Nat Prod,2010.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1317215,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,128.0
11878,,5145774,CHEMBL1662140,Antimicrobial activity against multidrug resistant Enterobacter aerogenes ATCC 15038 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,0.125
11879,,5145775,CHEMBL1660484,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae ATCC 11296 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.125
11880,,5145776,CHEMBL1660501,Antimicrobial activity against multidrug resistant Enterobacter aerogenes ATCC 15038 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,0.125
11881,,5145785,CHEMBL1662130,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 7 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.25
11882,,5145786,CHEMBL1660490,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 6 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.25
11883,,5145787,CHEMBL1660491,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 7 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.25
11884,,5145788,CHEMBL1660492,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 8 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.25
11885,,5145789,CHEMBL1660496,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 12 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.25
11886,,5145790,CHEMBL1660498,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 14 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.25
11887,,5145805,CHEMBL1662123,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae ATCC 11296 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.5
11888,,5145806,CHEMBL1660489,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 5 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.5
11889,,5145807,CHEMBL1660500,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 16 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.5
11890,,5145832,CHEMBL1662129,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 6 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
11891,,5145833,CHEMBL1662132,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 9 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
11892,,5145834,CHEMBL1662139,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 16 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
11893,,5146940,CHEMBL1662124,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 1 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
11894,,5146941,CHEMBL1662128,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 5 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
11895,,5146942,CHEMBL1662131,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 8 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
11896,,5146943,CHEMBL1662977,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 6 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,2.0
11897,,5146944,CHEMBL1660485,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 1 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
11898,,5146945,CHEMBL1660486,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 2 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,2.0
11899,,5146989,CHEMBL1662125,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 2 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,4.0
11900,,5147018,CHEMBL1662135,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 12 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
11901,,5147019,CHEMBL1662137,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 14 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
11902,,5147075,CHEMBL1660497,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 13 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,32.0
11903,,5147129,CHEMBL1661987,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 6 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,64.0
11904,,5147130,CHEMBL1662134,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 11 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
11905,,5147131,CHEMBL1660495,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 11 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
11906,,5147192,CHEMBL1661989,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 8 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,128.0
11907,,5147193,CHEMBL1661990,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 9 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,128.0
11908,,5147194,CHEMBL1662113,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 18 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,128.0
11909,,5147195,CHEMBL1662114,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 19 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,128.0
11910,,5147196,CHEMBL1662126,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 3 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,128.0
11911,,5147197,CHEMBL1662127,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 4 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,128.0
11912,,5147198,CHEMBL1662133,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 10 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,128.0
11913,,5147199,CHEMBL1662979,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 8 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,128.0
11914,,5147200,CHEMBL1662980,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 9 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,128.0
11915,,5147201,CHEMBL1660471,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 15 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,128.0
11916,,5147202,CHEMBL1660472,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 16 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,128.0
11917,,5147203,CHEMBL1660473,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 17 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,128.0
11918,,5147204,CHEMBL1660474,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 18 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,128.0
11919,,5147205,CHEMBL1660475,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 19 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,128.0
11920,,5147206,CHEMBL1660476,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 20 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,128.0
11921,,5147207,CHEMBL1660477,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 21 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,128.0
11922,,5147208,CHEMBL1660478,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 22 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,128.0
11923,,5147209,CHEMBL1660480,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 24 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,128.0
11924,,5147210,CHEMBL1660481,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 25 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,128.0
11925,,5147211,CHEMBL1660482,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 26 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,128.0
11926,,5147212,CHEMBL1660483,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 27 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,128.0
11927,,5147213,CHEMBL1660487,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 3 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,128.0
11928,,5147214,CHEMBL1660488,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 4 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,128.0
11929,,5147215,CHEMBL1660494,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 10 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,128.0
11930,,5147245,CHEMBL1661982,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 1 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,256.0
11931,,5147246,CHEMBL1661983,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 2 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,256.0
11932,,5147247,CHEMBL1661984,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 3 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,256.0
11933,,5147248,CHEMBL1661988,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 7 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,256.0
11934,,5147249,CHEMBL1661991,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 10 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,256.0
11935,,5147250,CHEMBL1662117,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 22 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,256.0
11936,,5147251,CHEMBL1662120,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 25 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,256.0
11937,,5147252,CHEMBL1662121,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 26 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,256.0
11938,,5147253,CHEMBL1662122,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 27 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,256.0
11939,,5147254,CHEMBL1662138,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 15 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,256.0
11940,,5147255,CHEMBL1662972,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 1 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,256.0
11941,,5147256,CHEMBL1662973,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 2 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,256.0
11942,,5147257,CHEMBL1662974,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 3 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,256.0
11943,,5147258,CHEMBL1662978,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 7 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,256.0
11944,,5147259,CHEMBL1662981,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 10 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,256.0
11945,,5147260,CHEMBL1662982,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 11 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,256.0
11946,,5147261,CHEMBL1660479,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 23 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,256.0
11947,,5147262,CHEMBL1660499,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 15 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,256.0
11948,,5147281,CHEMBL1661985,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 4 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,512.0
11949,,5147282,CHEMBL1661986,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 5 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,512.0
11950,,5147283,CHEMBL1661992,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 11 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,512.0
11951,,5148322,CHEMBL1661993,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 12 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,512.0
11952,,5148323,CHEMBL1662108,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 13 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,512.0
11953,,5148324,CHEMBL1662109,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 14 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,512.0
11954,,5148325,CHEMBL1662110,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 15 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,512.0
11955,,5148326,CHEMBL1662111,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 16 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,512.0
11956,,5148327,CHEMBL1662115,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 20 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,512.0
11957,,5148328,CHEMBL1662116,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 21 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,512.0
11958,,5148329,CHEMBL1662118,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 23 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,512.0
11959,,5148330,CHEMBL1662119,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 24 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,512.0
11960,,5148331,CHEMBL1662975,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 4 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,512.0
11961,,5148332,CHEMBL1662976,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 5 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,512.0
11962,,5148333,CHEMBL1662983,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 12 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,512.0
11963,,5148334,CHEMBL1662984,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 13 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,512.0
11964,,5148335,CHEMBL1662985,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 14 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,512.0
11965,,5148360,CHEMBL1660493,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 9 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.06
11966,,5148434,CHEMBL1662136,Antimicrobial activity against multidrug resistant Klebsiella pneumoniae isolate 13 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,>,1,1,>,MIC,ug.mL-1,256.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,256.0
11967,,5148435,CHEMBL1662112,Antimicrobial activity against multidrug resistant Enterobacter aerogenes isolate 17 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325680,>,1,1,>,MIC,ug.mL-1,512.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,512.0
11968,Not Determined,5148476,CHEMBL1662141,Antimicrobial activity against multidrug resistant Enterobacter aerogenes ATCC 15038 harboring pDrive plasmid by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,1325680,,1,0,,MIC,,,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,,,
11969,Not Determined,5148477,CHEMBL1662142,Antimicrobial activity against multidrug resistant Enterobacter aerogenes ATCC 15038 harboring pACM204 plasmid by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,1325680,,1,0,,MIC,,,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,,,
11970,Not Determined,5148478,CHEMBL1662143,Antimicrobial activity against multidrug resistant Enterobacter aerogenes ATCC 15038 harboring pDrive plasmid expressing ampC gene by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,1325680,,1,0,,MIC,,,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,,,
11971,Not Determined,5148479,CHEMBL1662144,Antimicrobial activity against multidrug resistant Escherichia coli DH5[alpha] by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,1325680,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
11972,Not Determined,5148480,CHEMBL1662145,Antimicrobial activity against multidrug resistant Escherichia coli DH5[alpha] harboring pDrive plasmid by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,1325680,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
11973,Not Determined,5148481,CHEMBL1662146,Antimicrobial activity against multidrug resistant Escherichia coli DH5[alpha] harboring pDrive plasmid expressing ampC gene by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,1325680,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
11974,Not Determined,5148482,CHEMBL1662147,Antimicrobial activity against multidrug resistant Escherichia coli DH5[alpha] harboring pACM204 plasmid by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,1325680,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
11975,Not Determined,5148483,CHEMBL1662148,Antimicrobial activity against multidrug resistant Escherichia coli ATCC 35218 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,1325680,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
11976,Not Determined,5148484,CHEMBL1662149,Antimicrobial activity against multidrug resistant Escherichia coli ATCC 35218 harboring pDrive plasmid by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,1325680,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
11977,Not Determined,5148485,CHEMBL1662150,Antimicrobial activity against multidrug resistant Escherichia coli ATCC 35218 harboring pDrive plasmid expressing ampC gene by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,1325680,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
11978,Not Determined,5148486,CHEMBL1660643,Antimicrobial activity against multidrug resistant Enterobacter aerogenes ATCC 15038 harboring pDrive plasmid by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,1325680,,1,0,,MIC,,,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,,,
11979,Not Determined,5148487,CHEMBL1661367,Antimicrobial activity against multidrug resistant Enterobacter aerogenes ATCC 15038 harboring pACM204 plasmid by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,1325680,,1,0,,MIC,,,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,,,
11980,Not Determined,5148488,CHEMBL1661368,Antimicrobial activity against multidrug resistant Enterobacter aerogenes ATCC 15038 harboring pDrive plasmid expressing ampC gene by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,1325680,,1,0,,MIC,,,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,,,
11981,Not Determined,5148489,CHEMBL1661369,Antimicrobial activity against multidrug resistant Escherichia coli DH5[alpha] by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,1325680,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
11982,Not Determined,5148490,CHEMBL1661370,Antimicrobial activity against multidrug resistant Escherichia coli DH5[alpha] harboring pDrive plasmid by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,1325680,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
11983,Not Determined,5148491,CHEMBL1661371,Antimicrobial activity against multidrug resistant Escherichia coli DH5[alpha] harboring pDrive plasmid expressing ampC gene by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,1325680,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
11984,Not Determined,5148492,CHEMBL1661372,Antimicrobial activity against multidrug resistant Escherichia coli DH5[alpha] harboring pACM204 plasmid by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,1325680,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
11985,Not Determined,5148493,CHEMBL1661373,Antimicrobial activity against multidrug resistant Escherichia coli ATCC 35218 by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,1325680,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
11986,Not Determined,5148494,CHEMBL1661374,Antimicrobial activity against multidrug resistant Escherichia coli ATCC 35218 harboring pDrive plasmid by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,1325680,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
11987,Not Determined,5148495,CHEMBL1661375,Antimicrobial activity against multidrug resistant Escherichia coli ATCC 35218 harboring pDrive plasmid expressing ampC gene by broth dilution method in presence of 26.3 mg/L efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649134,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,,1325680,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
11988,,5148814,CHEMBL1661655,Antimicrobial activity against Escherichia coli K-12 BW25113 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649176,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326009,=,1,1,=,MIC,ug.mL-1,0.04,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.04
11989,,5148815,CHEMBL1661656,Antimicrobial activity against sodB gene-deficient Escherichia coli K-12 DKsodB by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649176,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326009,=,1,1,=,MIC,ug.mL-1,0.04,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.04
11990,,5148816,CHEMBL1661657,Antimicrobial activity against sodA gene-deficient Escherichia coli K-12 3144 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649176,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326009,=,1,1,=,MIC,ug.mL-1,0.04,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.04
11991,,5148817,CHEMBL1661658,Antimicrobial activity against sodB gene-deficient Escherichia coli K-12 3145 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649176,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326009,=,1,1,=,MIC,ug.mL-1,0.04,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.04
11992,,5148818,CHEMBL1661659,"Antimicrobial activity against sodA, sodB gene-deficient Escherichia coli K-12 3156 by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649176,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326009,=,1,1,=,MIC,ug.mL-1,0.04,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.04
11993,,5148819,CHEMBL1661660,Antimicrobial activity against katG gene-deficient Escherichia coli K-12 3157 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649176,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326009,=,1,1,=,MIC,ug.mL-1,0.04,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.04
11994,,5148820,CHEMBL1661661,Antimicrobial activity against ahpC gene-deficient Escherichia coli K-12 3200 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649176,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326009,=,1,1,=,MIC,ug.mL-1,0.04,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.04
11995,,5148821,CHEMBL1661662,"Antimicrobial activity against katG,katE gene-deficient Escherichia coli K-12 3201 by broth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649176,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326009,=,1,1,=,MIC,ug.mL-1,0.08,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.08
11996,,5148822,CHEMBL1661663,Antimicrobial activity against katE gene-deficient Escherichia coli K-12 3202 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649176,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326009,=,1,1,=,MIC,ug.mL-1,0.04,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.04
11997,,5148823,CHEMBL1661684,Bactericidal activity against Escherichia coli K-12 BW25113 after 18 hrs,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649176,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326009,=,1,0,=,MBC,ug ml-1,0.32,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.32
11998,,5148824,CHEMBL1661812,Bactericidal activity against sodB gene-deficient Escherichia coli K-12 DK after 18 hrs,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649176,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326009,=,1,0,=,MBC,ug ml-1,0.32,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.32
11999,,5148825,CHEMBL1662437,Bactericidal activity against sodA gene-deficient Escherichia coli K-12 3144 after 18 hrs,F,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,CHEMBL1649176,Antimicrob Agents Chemother,2009.0,CHEMBL9,NORFLOXACIN,CHEMBL9,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326009,=,1,0,=,MBC,ug ml-1,0.32,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.32
